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1 SUMMARY
This thesis set out to investigate the role of Prostaglandin F-2a (PGF-2a) in 
luteolysis in the mare and to determine any alterations in PGF-2a production between 
normal cycling mares and mares in prolonged dioestrus.
As luteolysis is not overtly expressed, a method for determining the expected time 
of luteolsysis had to be established. Four mares were examined by ’teasing’ with a stal­
lion, examination of the reproductive tract per rectum and plasma progesterone estima­
tions. These investigations allowed expertise to be gained in determining the day of 
ovulation which was counted as Day 0. Thirteen days were counted forward to 
determine the expected time of luteolysis.
In an attempt to establish the PGF-2a pattern of release at luteolysis the metabo­
lite 13,14 dihydro 15 keto PGF-2a (PGFM) was measured in the plasma as an accurate 
marker for PGF-2a release. A PGFM radio-immunassay was therefore modified and 
eleven mares were blood sampled and the plasma was assayed for PGFM concentra­
tions. The mares were bled under different blood sampling regimes and an overall pat­
tern of PGFM release became apparent. At Day 14 post-ovulation a series of pulses was 
observed in the plasma which increased in frequency until they appeared to be 
terminated by the largest PGFM pulse. This pattern appeared to be crucial to the out­
come of luteolysis. Three out of the eleven mares did not return to standing oestrus des­
pite demonstrating raised PGFM concentrations in the circulating plasma. The pattern 
of release in these mares appeared altered compared to the normal cycling mares. Also 
the overall concentrations released appeared reduced and these two factors may have 
resulted in the mares remaining in a state of prolonged dioestrus. Two of the mares in 
prolonged dioestrus had uterine biopsies taken and both returned to standing oestrus 
within five days of the biopsy. No significant pulses of PGFM were picked up in the 
plasma during and for several hours after uterine biopsy but this could have been due to 
inadequate blood-sampling regimes in the mares involved. As the mares in prolonged 
dioestrus appeared to be capable of a degree of prostaglandin release, it was queried 
whether a secondary source of PGF-2a was present in the mare, which was not being 
stimulated in the mares in prolonged dioestrus.
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The ovary seemed the obvious place for a secondary source of PGF-2a, in par­
ticular the corpus luteum (CL), therefore a tissue culture method and a PGF-2a 
radio-immunassay were established. Sections of luteal tissue and, as a comparison, 
endometrial tissue were collected and frozen in liquid nitrogen before culturing in vitro 
to determine PGF-2a production by the tissues at the different stages of the oestrous 
cycle. However as no reproductive history of the mares was known, histology of the 
luteal tissue was used to group the mares into early, mid, late luteal and follicular 
phases.
The luteal tissue appeared to be capable of PGF-2a at all stages of the oestrous 
cycle but it was during the late luteal phase, around the expected time of luteolysis that 
the most significant increase in PGF-2a production by the tissue was observed. This 
increase was thought to be involved in luteolysis, as no decrease in plasma or tissue 
progesterone concentration was observed. It appeared therefore that the mare had a 
secondary source of PGF-2a release in the CL which in some way supplemented the 
PGF-2a from the uterine endometrium. Any breakdown in communication between the 
two areas may lead to the mare not returning to standing oestrus and entering a state of 
prolonged dioestrus.
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CHAPTER ONE 
GENERAL INTRODUCTION
1.1 Introduction
The oestrous cycle of the mare can be divided into the follicular or standing 
oestrous phase, during which time the mare will accept mating, and the luteal or 
dioestrous phase, when the mare rejects the stallion. During the luteal phase of the 
oestrous cycle a temporary endocrine gland, the corpus luteum (CL) formed from 
the remnants of the ovulated follicle, is present in the ovary. This gland secretes the 
steroid hormone progesterone, which is essential for the establishment and mainten­
ance of pregnancy, by maintaining a suitable uterine environment for the growth 
and development of the conceptus.
1.2 Origins of the corpus luteum
In the mare as in all the domestic species, corpus luteum formation occurs 
after ovulation of the mature follicle (Ginther, 1979). The follicle that is destined to 
ovulate grows and develops rapidly during standing oestrus, reaching a size of 
60-70mm in Thoroughbred mares at ovulation (Ginther, 1979). Throughout this 
period of growth and maturation, the developing follicles secrete increasing concen­
trations of the steroid hormone oestradiol, principally oestradiol P, which enters the 
circulation and brings about ’switching on’ of the behavioural centres and the mares 
acceptance of the stallion (Noden, Oxender and Hafs, 1975). Both granulosa and 
theca cells are involved in the production of oestradiol p in maturing follicles.
During the early stages of follicular growth the theca interna layer undergoes 
marked capillary invasion and increased androgen production, while the granulosa 
cell layer also undergoes growth and development and is concerned with the aro- 
matisation of androgens to oestrogens. The more vascular follicles are usually 
found to have the highest steroid content (Younglai, 1971).
The follicular changes are initiated by Follicle Stimulating Hormone (FSH), a 
gonadotrophin which is released in a bimodal surge pattern from the anterior pitu­
itary (Evans and Irvine, 1975). One of the two FSH surges is reported to occur dur­
ing dioestrus, 10-13 days prior to ovulation in all mares, despite the extreme 
variability of oestrous cycle length in the mares. This mid-dioestrous increase in
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FSH is thought to be responsible for the development of the follicle destined to ovu­
late during the following standing oestrus. A controlling mechanism of FSH syn­
thesis and release from the anterior pituitary in the mare has now been established. 
This is thought to be the compound inhibin, produced by the granulosal cells of the 
follicle and found in the follicular fluid. Inhibin, in conjuction with oestradiol, acts 
by negative feedback directly on the anterior pituitary to suppress FSH production 
(Franchimont et al, 1979). Due to the stimulate actions of FSH an average of 3.5 
follicles attain a size of 20-25mm prior to standing oestrus in the mare (Irvine,
1981). However usually only one of these follicles will mature fully and ovulate 
while the others will become atretic. Reports suggest that the follicle destined to 
ovulate is selected very early in standing oestrus and indeed is probably selected 
prior to overt behavioural oestrus (Irvine, 1981).
The factors controlling the destiny of the developing follicles are very poorly 
understood but recently it has been reported that the follicle with the highest con­
centrations of oestrogen is the one which ovulates.
Subsequent growth and maturation of the follicle, after this pre-ovulatory 
growth, is luteinising hormone-dependent and occurs relatively rapidly.
In most of the domestic species other than the mare, luteinising hormone (LH) 
is released in a pulsatile pattern with a sudden, large, short-lived surge occurring 
just prior to ovulation (Baird, Swanston and Scaramuzzi, 1976). However in the 
mare the pattern of LH secretion is very different.
In this species LH concentrations do not reach a sudden peak around ovulation 
but show a gradual increase in the circulating concentrations during late dioestrus, 
reaching a peak about 18-24 hours after ovulation, after which there is a gradual 
decrease in the circulating concentrations to baseline during early dioestrus (Hughes 
et al, 1980; Urwin and Allen, 1983).
In the mare LH release appears to be episodic in nature but the amplitude and 
frequency of the pulses varies greatly between mares and within mares during dif­
ferent stages of the oestrous cycle. No uniformity in the pattern of this pulsatile 
release is apparent within a group of mares, however this episodic release of LH is 
superimposed onto an increasing baseline concentration in all mares such that the 
overall concentration of LH is increasing markedly towards ovulation (Evans et al, 
1979).
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Unlike the other domestic species the half-life of LH in the plasma of the mare 
is very long (about 1.5-1.8 days) and this slow metabolism is reflected by the pro­
longed elevated LH concentrations demonstrated in the circulating plasma (Gesh- 
wind et al, 1975). The mare therefore has significantly elevated LH for almost one 
half of her 21 day cycle. The reason for this pattern of LH release in the mare has 
not been elucidated. However these prolonged high levels of LH appear to be 
responsible for the long standing oestrous period of the mare (5-6 days) and in addi­
tion may explain why double ovulations, with the second occurring as late as 4 days 
after the first, are frequently reported in the mare (Stabenfeldt, Hughes and Evans, 
1972).
1.3 Ovulation
During their development the follicles grow close to, and protrude from, the 
ovarian surface until prior to ovulation when migration to the hilus, or ovulatory 
fossa, of the ovary occurs (Witherspoon and Talbot, 1970). This hilus, unlike the 
rest of the ovarian surface, is not surrounded by peritoneum and is in close apposi­
tion to the infundibulum. Thus, in the mare, ovulation is only able to occur from this 
site.
Although the exact events involved in the ultimate release of the ovum have 
not been fully established there is an increasing body of evidence to suggest that 
prostaglandins are closely involved in the ovulatory process (Armstrong, 1986). 
Significant concentrations of prostaglandin F-2a (PGF-2a) and prostaglandin E-2 
(PGE-2) are present in the follicular fluid prior to ovulation and the inflammatory 
changes evident in the membrane of the follicle appear to be mediated by PGF-2a 
and PGE-2. LH stimulation of the ovulatory follicle leads to an increase in the 
intracellular concentrations of the enzymes involved in prostaglandin synthesis. 
PGF-2a and PGE-2 also stimulate the release of plasminogen activator substance, 
responsible for the conversion of plasminogen to plasmin, which is involved in the 
breakdown of the follicle wall at ovulation (Poyser, 1981). Contractions of the' 
ovarian tissue around the ovulatory follicle assisting in the expulsion of the ovum 
also occur and are thought to be mediated by the prostaglandins.
1.4 Formation of the corpus luteum
Immediately after ovulation the follicle wall collapses, in a highly folded state, 
into the space left by the escaping ovum and the space gradually fills with blood to
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form the corpus haemorrhagicum (Van Nierkerk, 1975). This structure can be pal­
pated per rectum as a large soft depression in the ovarian substance, often represent­
ing about 70% of the size of the original follicle (Ginther, 1979). The corpus 
haemorrhagicum gradually undergoes luteinisation of the granulosa cells with 
subsequent hypertrophy and hyperplasia of the cells to produce the fully functional 
corpus luteum (CL). By Day 3 post-ovulation luteinisation of the granulosa cells is 
complete and by Day 4 post-ovulation the CL has reached its maximum size (Van 
Nierkerk, 1975).
Recently several authors have proposed a two cell model for the structure of 
the CL in the ewe and the cow (Fitz et al, 1982: Fitz et al, 1984: Schwall et al, 
1986). The two cells, termed large and small cells based on the variation in their 
size, appear to be physiologically distinct although capable of interaction. Schwall 
et al (1986) reported PGF-2a receptor sites only on the cell membrane of the large 
cells. As both cells are capable of progesterone production they must both be lysed 
at luteolysis to reduce the circulating plasma progesterone to baseline.
As the CL matures it gradually organises to become brown and more fibrous 
with a gradual reduction in size. Subsequently, due to ageing, the colour alters from 
brown to yellow/orange as the amount of pigment increases. Lysis of the CL occurs 
around Day 14 post-ovulation in the mare with plasma progesterone reaching base­
line prior to standing oestrus (Neely et al, 1979). The biochemical changes 
observed in the CL during luteolysis appear to be separate from the structural 
changes observed as the CL ages. The biochemical changes are referred to as func­
tional luteolysis and the structural changes as structural luteolysis (Horton and 
Poyser, 1976). It seems likely that the mare resembles the ewe in this aspect of 
reproduction in that the functional luteolytic changes precede the structural changes 
but both are mediated by PGF-2oc. PGF-2a has been reported to increase the release 
of lysosmal enzymes in the luteal cells of the rat and these enzymes may be respon­
sible for the structural changes observed in the luteal cells (Poyser, 1981).
The CL is responsible for the secretion of the steroid hormone progesterone 
which is synthesised from the precursor cholesterol by the granulosa cells (Ginther, 
1979). Within 24 hours of ovulation some of the luteinised granulosa cells are 
actively synthesising and secreting progesterone (Vans Rensburg and Van Nierkerk, 
1968: Van Nierkerk, 1975). Progesterone concentration increases rapidly in the 
plasma during this time to reach a plateau by Day 6 post-ovulation (Palmer, 1978).
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The ratio of increased progesterone concentration to decreased oestrogens is thought 
to be responsible for ’switching off’ overt oestrous behaviour and the mare’s rejec­
tion of the stallion (Noden, Oxender and Hafs, 1975). The luteal cells continue to 
secrete progesterone until Day 14 of the oestrous cycle when, if pregnancy is not 
established, lysis of the CL takes place and progesterone secretion is terminated 
(Oxender et al, 1974).
The gonadotrophin LH and possibly FSH appear to be vital for the growth, 
development and function of the CL of the mare. Pineda et al (1973) demonstrated 
that if antisera to LH was injected into mares in early dioestrus the CL did not 
develop normally but showed signs of early degeneration with no increase in the 
circulating plasma progesterone. However the antisera may have had some FSH 
activity as well as LH, as it consisted of a crude pituitary extract and therefore FSH, 
along with LH, may have been responsible for the effects observed. However in the 
mare, as in many of the domestic species, receptors for LH but not FSH have been 
identified on the cell surface of the luteal cells (Kimball and Wynegarden, 1977). 
Stewart and Allen (1979) reported that in the mare the LH receptors have a higher 
specificity for LH than the LH receptors of the other domestic species. The binding 
of LH to the receptors on the luteal cell membranes leads to an intracellular increase 
in cyclic adenosine monophosphate (cAMP) synthesised from adenosine triphos­
phate (ATP) (Richardson, 1987). This reaction is catalyzed by the enzyme adeny­
late cyclase bound to the cell membrane and triggered by the binding of LH to the 
LH receptor site. Cyclic AMP is a vital co-factor in the synthetic pathway of 
progesterone and an increase in the concentration of cAMP leads to an increased 
synthesis and release of progesterone from the luteal cells. However some authors 
report that progesterone synthesis and release by the CL is not solely dependent on 
the stimulatory action of LH and that the CL is capable of autonomous secretion of 
progesterone, for at least part of the oestrous cycle in most of the domestic species 
(Rothchild, 1981). Progesterone therefore apparently acts as a positive stimulus for 
the continued synthesis of progesterone. Indeed reports show that the CL of the 
ewe, guinea pig and pig can grow and secrete progesterone after hypophysectomy 
for almost the whole luteal phase (Rothchild, 1981). PGE-2 has also been suggested 
as a luteotrophic agent mimicking the effects of LH at its receptor site (Massicote et 
al, 1984). However little is known of the circulating plasma PGE-2 concentrations 
throughout the oestrous cycle in the mare. As previously discussed, a wave of FSH
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is recorded during dioestrus in the mare which appears to stimulate a mid-dioestrous 
wave of follicles. However the fact that this wave of FSH may have a role to play 
in the stimulation of progesterone secretion cannot be ruled out, particularly in the 
mare in which so little is known of the stimulating and controlling mechanisms of 
the CL.
1.5 Life-span of the corpus luteum
In cycling mares with an interoestrous period of 15-17 days, lysis of the CL 
occurs around Day 14 post-ovulation (Neely et al, 1979). This results in a decline 
in circulating plasma progesterone to baseline and is considered to be mediated by 
the luteolysin PGF-2a, synthesised and released from the uterine endometrium of 
the mare (Neely et al, 1979). The decline in the circulating plasma progesterone 
occurs over the following 36-48 hours. The importance of the uterus in luteolysis in 
the mare was first reported by Ginther and First (1971) who observed that hysterec­
tomy in the mare significantly prolonged the lifespan of the CL. PGF-2a has been 
positively identified as the luteolysin in the ewe, the species in which most of the 
work in this field has concentrated (McCracken et al, 1972: Goding, 1974). In the 
mare, as in the ewe, there is an increase in the circulating plasma PGF-2a around 
the time of luteolysis. In addition exogenous prostaglandin administered during 
dioestrus effects a return to standing oestrus within 2-5 days in the mare (Allen and 
Rowson, 1973: Allen and Cooper, 1975: Kenney et al, 1975). Therefore workers in 
the field hypothesized that, as in the ewe, PGF-2a was the luteolysin in the mare 
(Douglas and Ginther, 1976).
1.6 Prostaglandins: Chemistry, synthesis and metabolism.
As far as reproduction is concerned the most important prostaglandins are 
PGE-2 and PGF-2a. The exact role of PGE-2 has not been fully established but it 
appears to have luteotrophic properties and may be involved in the maternal rec­
ognition of pregnancy, acting to combat the luteolytic actions of PGF-2a (Richard­
son, 1986). The role of PGF-2a has been more fully investigated and although not 
fully understood, this compound does appear to be directly involved in luteolysis.
Both PGE-2 and PGF-2a are 20 carbon long-chain fatty acids with double 
bonds at C5 and C13 and a 15(S) hydroxyl group which seems to be important for 
their biological activity. Their differences arise in the structure of the functional 
groups of the cyclo-pentane ring, PGF-2a differing from PGE-2 only in the pres­
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ence of a hydroxyl group attached to the cyclo-pentane ring in place of an oxo group 
(Poyser, 1981).
The prostaglandins PGF-2a and PGE-2 are synthesised from the common pre­
cursor arachidonic acid (Figure 1:1, Lands, 1979). Arachidonic acid (AA) is stored 
in esterified form as arachidonate in the phospholipid fraction of the cell membrane. 
A variety of stimuli are able to release AA from the membrane bound glycerophos- 
pholipid, mainly through hydrolysis by phospholipase A (PLA-2) and phospholi- 
pase C (PLC: Vogt, 1978). However there appears to be different endogenous pools 
of AA present in the cell membrane. PLA-2 appears to be responsible for release of 
AA destined to be the precursor of PGF-2a while PLC releases AA for PGE-2 syn­
thesis (Poyser, 1987). The concentration of free AA available within the cell is nor­
mally extremely low, unless the cell is stimulated, therefore the release of free AA 
is considered to be the rate-limiting step in the biosynthesis of prostaglandins 
(Leaver and Poyser, 1981). Around Day 14 post-ovulation in the mare there is an 
increased release of AA from the endometrial cell membrane due to increased 
PLA-2 activity. This leads to increased PGF-2a synthesis due to the actions of 
complex microsomal enzymes, the first of which is fatty acid cyclo-oxygenase 
(Lands, 1979). Cyclo-oxygenase catalyses the oxygenation of AA to the endoper- 
oxide PGG-2 and is readily inhibited by the non-steroidal anti-inflammatory drugs 
(NSAID), such as aspirin and indomethacin (Vane, 1971: Poyser, 1985). PGG-2 is 
rapidly converted into the peroxide PGH-2 by the action of a peroxidase enzyme. 
These intermediates are biologically very potent, being strong inducers of platelet 
aggregation, vasoconstriction and contraction of respiratory smooth muscle among 
other reactions. However they are transitory compounds with half-lives of about 8 
seconds and so their actions tend to be exerted in close proximity to their tissues of 
origin (Poyser, 1981). The endoperoxides are rapidly converted into a number of 
different compounds, the classical primary prostaglandins, PGF-2a, PGE-2 and 
PGD-2 among others, by the specific actions of an appropriate enzyme (Poyser, 
1984a). PGF-2a can be synthesised in three different ways from the endoperoxide 
PGH-2. Firstly PGH-2 can be reduced to produce PGF-2oc. This reaction is thought 
to be enzymatically controlled (Poyser, 1984a). The second pathway is the conver­
sion of PGE-2 into PGF-2a by the actions of the enzyme 9-keto-reductase. The 
third method is the reduction of the 11-oxo group of PGD-2.
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Although the prostaglandins have a high biological potency they are rapidly meta­
bolised to essentially inactive compounds. The organs mainly responsible for pro­
staglandin metabolism are the lungs (Piper, Vane and Wyllie, 1970), although to a 
lesser extent metabolism also takes place in the liver and kidneys (Samuelsson et al, 
1975). The first metabolic attack by 15 hydroxyl prostanoate dehydrogenase con­
verts the 15 hydroxyl group to an oxo group very rapidly. This is then followed by 
reduction of the C3 double bond by a reductase enzyme, further reducing the 
potency to produce 15 keto-13,14 dihydro prostaglandin F-2a (PGFM). This meta­
bolite has a much longer half-life than the parent compound and so PGFM is more 
readily measured in the plasma. Assays on the plasma of the domestic species 
therefore record PGFM concentrations as an indicator of the circulating plasma pro­
staglandin concentrations (Granstrom and Kumlin, 1987).
The major final degradation products are excreted in the urine after extensive 
oxidisation in the liver to the tetranor metabolites. These compounds have an even 
longer half-life than the 15 keto-13,14 dihydroprostaglandin metabolite, and have 
therefore been measured by some authors to gain further information about prosta­
glandin concentrations in the circulating plasma (Kindahl et al, 1984). However 
both plasma and urine analysis of PGF-2a metabolites gives no indication of site of 
synthesis and release of the parent compound.
The prostaglandins PGF-2a and PGE-2 can have another metabolic fate. The 
presence of a prostaglandin-9-oxo reductase, which is capable of catalysing the 
reduction of the 9-oxo group at C9 in PGE-2 to form PGF-2 compounds is found in 
many tissues including the ovary (Watson et al, 1979). The reverse reaction in 
which the formation of PGE compounds from PGF-2 by the enzyme prostaglandin 
9-hydroxyldehydrogenase has also been reported. Although these reactions may 
occur more frequently in some species than in others, they may be a vital pathway 
in the alteration of the proportion of the two compounds (Oliw, Granstrom and Ang- 
gard, 1981).
1.7 Stimuli for prostaglandin release
It is apparent that no single stimulatory factor is involved in the stimulation of 
prostaglandin synthesis but a complicated interaction of many separate factors.
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Several authors report that oestrogens play an important role in the stimulation 
of PGF-2a production from the endometrial cells and indeed, in most of the domes­
tic species, an increase in the circulating oestrogen concentration is observed prior 
to, or during, the luteolytic increase in PGF-2a (Poyser, 1981). However 
exogenous oestrogens only stimulate PGF-2a production from the uterus if the 
uterus has had previous exposure to progesterone for a period of at least 10 days 
(Blatchley and Poyser, 1974: McCracken et al, 1981). In the mare the dioestrous 
wave of follicles, releasing increasing concentrations of oestrogens, may be 
involved in stimulating an increase in PGF-2a synthesis and release from the 
progesterone-primed uterus. Work done to date on the guinea pig suggests that oes­
trogens are able to passage into the nucleus of the endometrial cell and act on the 
DNA surface to stimulate DNA synthesis (Horton and Poyser, 1976). RNA then 
increases the synthesis of the enzymes involved in PGF-2a synthesis. Oestrogens 
are also capable of increasing the intracellular calcium concentration responsible for 
triggering the PLA-2 enzyme. This enzyme is optimally active in the guinea pig 
uterus at a concentration of 7mM Ca2 (Downing and Poyser, 1983). An increased 
intracellular calcium concentration will therefore lead to activation of the enzymes 
and the release of AA from the cell membrane. This effect, coupled with the intra­
cellular increase in PGF-2a synthetic enzymes, may be an important aspect of the 
oestrogen stimulation of prostaglandin production.
Although it appears essential that the uterus is first primed with progesterone 
before oestrogen can stimulate the synthesis of prostaglandin, the exact role of pro­
gesterone has not been clarified. Sar and Stumpf (1974) showed that progesterone 
enters the nucleus of the cell in a similar manner to that of oestrogen, but the nuclear 
response to the presence of progesterone remains unclear. Poyser (1981) suggests 
that progesterone is involved in the release of AA from its bound source in the cell 
membrane.
However oestrogens acting on a progesterone-primed uterus are not the only 
stimulatory factors involved in the release of PGF-2a from the uterus. As early as 
1959, Armstrong and Hansell recognized that exogenous oxytocin, infused into 
cycling cows during dioestrus, resulted in an early return to standing oestrus.
Recent evidence in the ewe suggests that the luteolytic effect of oxytocin is 
mediated via the release of prostaglandins from the uterus and many authors now 
believe that oxytocin is intimately involved in the process of luteolysis in several
12
species (Flint and Sheldrick, 1983: Sheldrick, Mitchall and Flint, 1980 :McCracken 
etaU 1981: Cooke andHomiedia, 1982 and 1983: Mitchell etal, 1982: Mitchell, 
Flint and Tumball, 1975). However the evidence for the involvement of oxytocin in 
the oestrous cycle of the mare is a confused and contradictory one. Neely et al, 
(1979b) were unable to induce precocious oestrus in mares with the administration 
of exogenous oxytocin, although Goff et al (1987) reported increased plasma pro­
staglandin in response to exogenous oxytocin. Tetzke et al (1987), using an inten­
sive programme of blood collections, reported that the circulating concentration of 
oxytocin fluctuated markedly throughout the oestrous cycle of the mare. The 
concentrations increased during mid to late dioestrus and declined during oestrus. 
This pattern resembles that reported in the ewe, although actual concentrations of 
oxytocin are higher in the mare than in the ewe. Bums et al (1981) also reported 
that the concentrations of oxytocin fluctuated throughout the oestrous cycle of the 
mare but they reported that the concentrations reached a peak during oestrus and 
early dioestrus with baseline concentrations throughout mid to late dioestrus and no 
increase at the time of luteolysis.
In the ewe however the role of oxytocin is clearer and in a series of experi­
ments Flint and Sheldrick were able to demonstrate that plasma oxytocin fluctuated 
throughout the oestrous cycle of the ewe, rising during mid dioestrus but declining 
during prostaglandin mediated luteolysis (Sheldrick and Flint, 1981: Flint and Shel­
drick, 1983).
In the ewe and the cow the source of oxytocin appears to be the ovary and a 
precursor molecule for oxytocin has been identified in the cells of the bovine CL 
(Wathes et al, 1983). In these species oxytocin is thought to attach to receptor sites 
in the endometrium specific for oxytocin, thus stimulating the release of prostaglan­
din (Roberts et al, 1976: Sheldrick and Flint, 1985). McCracken et al, (1981) 
suggest that oestrogens act on the progesterone-primed uterus not only to stimulate 
prostaglandin synthesising enzymes but also to increase the concentration of oxyto­
cin receptors on the endometrial cell surface and to increase the binding of free oxy­
tocin to these receptor sites. The coupling of oxytocin to the endometrial receptor 
sites leads to an increase in the synthesis and release of PGF-2a from the cells. 
However Poyser (1984b) reported that the release of PGF-2a occurred from Day 12 
post-ovulation in the ewe, 2 days before the endometrium became sensitive to the
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effects of oxytocin, thus suggesting that oxytocin is not initially involved in the 
release of PGF-2a
1.8 Patterns of prostaglandin release
Once stimulated, prostaglandin synthesis and secretion proceed rapidly. The 
endometrial cell does not store prostaglandin but secretes it immediately (Piper and 
Vane, 1971). In the mare Stabenfeldt et al (1981) reported that around Day 14 
post-ovulation, PGF-2a was released into the plasma as a series of short-lived sur­
ges or pulses. The pulses of PGF-2a were released over a timespan of 36-48 hours 
and apparently resulted in a sequential drop in plasma progesterone to baseline. The 
mares were observed to return to standing oestrus within 6-7 days of the first release 
of PGF-2a. A pulsatile pattern of PGF-2a release has been identified in all the 
domestic species which depend on the uterus as the major source of PGF-2a (Hor­
ton and Poyser, 1976: Poyser, 1981). Although the controlling mechanism of this 
pulsatile release of PGF-2a remains unclear, many authors suggest that oxytocin is 
the ’pulse generator’ for prostaglandin release (Flint and Sheldrick, 1983: 
McCracken et al, 1981). Flint and Sheldrick (1983) reported that the CL will 
release oxytocin in a pulse representing the total amount of oxytocin synthesised by 
the cells at any one time. Oxytocin will attach to the receptor sites on the cell mem­
branes of the endometrial cells and stimulate PGF-2a release in a pulsatile pattern. 
McCracken etal, (1981) suggested that the episodic release of PGF-2a was due to 
down-regulation of the oxytocin receptor sites in the endometrium which took some 
time to recover and as a result no PGF-2a was released during the recovery period. 
Poyser (1984b) however reported that the pulsatile release of PGF-2a occurred 
independently of the hormonal status of the animal and that the pattern of prosta­
glandin release was an intrinsic property of the uterus and did not depend on hor­
monal stimuli. Due to destruction of cyclo-oxygenase during PGF-2a synthesis 
new ’batches’ of cyclo-oxygenase have to be produced thus leading to delays in 
PGF-2a synthesis and a pulsatile pattern of release (Poyser, 1981).
1.9 Transportation of prostaglandin to the site of action
Once the prostaglandins have been synthesised in the uterus they must travel 
to their site of action in the ovary. In ruminants prostaglandins travel to the ovary 
via the counter-current exchange system (McCracken et al, 1973: Einer-Jensen and 
McCracken, 1981: Ginther, 1974). This system is a complicated plexus involving
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the uterine vein and the ovarian artery, such that the walls of the vein and the artery 
are in very close apposition. Due to the varying tensions between the uterine vein 
and ovarian artery prostaglandins are able to pass directly from one to the other.
Thus a very concentrated surge of PGF-2a in its unmetabolised form is able to 
reach the ovary of the ruminant without first passing through the lungs. The import­
ance of this local exchange of substances in the oestrous cycle of the ewe is readily 
demonstrated when separation of the ovarian artery and uterine vein is carried out, 
as it leads to persistence of the CL beyond the normal interoestrous period, despite 
increased plasma PGF-2a concentrations (Barrett et al, 1971:Abdel Rahim et al, 
1984). However in the mare the uterine vein and ovarian artery are not closely 
apposed and no exchange of substances is possible between them (Ginther, 1974a). 
The absence of this local transfer system is easily demonstrated by partial hysterec­
tomy of the ipsilateral hom (Ginther and First, 1971). In the mare, unlike the rumi­
nant, this had no effect on the lifespan of the CL which was lysed as the 
concentrations of PGF-2a increased in the plasma. This would suggest that the 
prostaglandin may travel to the ovary via a systemic rather than a local pathway.
1.10 Mode of action of prostaglandins at the corpus luteum
Various theories have been suggested as to the mechanisms involved in the 
PGF-2a mediated lysis of the CL. In 1970 Pharriss suggested that vasoconstriction 
mediated by PGF-2a may cause death of the CL due to a lack of nutrients reaching 
the ovary. More recent reports suggest that there is little alteration to the overall 
ovarian blood flow during luteolysis, although luteal blood flow appears to be selec­
tively reduced. However this reduction in luteal blood flow occurs after progester­
one has begun to decline (Horton and Poyser, 1976: Einer-Jensen and McCracken, 
1977). It is not apparent therefore if the reduction in ovarian blood flow is a cause or 
an effect of luteolysis.
Labhetswar (1973) suggested that cessation of luteal function resulted from 
altered gonadotrophin secretion by the anterior pituitary. This work suggested that 
PGF-2a inhibited gonadotrophin hormone secretion at the pituitary. However 
Jochle et al (1987) reported that if circulating progesterone concentrations are low 
then an increase in circulating plasma LH and FSH is observed in response to 
PGF-2a administration in the mare. In addition Poyser (1981) reported that 
PGF-2a is a vital trigger for the release of gonadotrophin from the hypothalamus. 
This would suggest that PGF-2a will stimulate, not inhibit gonadotrophin secretion
15
at the pituitary. Behrman (1979), and Strauss and Stambaugh (1974) suggested an 
anti-gonadotrophic effect at the CL with a direct effect on the progesterone secre­
tory function. This theory has been strongly favoured by many authors. Vernon et 
al (1979) demonstrated the existence of definite PGF-2a receptor sites on the luteal 
cell membranes of the mare. Kimball and Lauderdale (1975) also reported the 
existence of separate PGF-2a, PGE-2 and LH receptor sites on the surface mem­
brane of bovine luteal cells. This suggested that PGF-2a acted independently of the 
LH receptor sites and not by a process of competitive binding at the LH receptor 
sites.
PGF-2a is thought to react with its receptors on the luteal cell membrane and 
uncouple the adenylate cyclase:cAMP system, by which LH stimulates the proges­
terone synthetic pathway (Horton and Poyser, 1976). This prevents the LH depend­
ent cAMP accumulation within the cell, possibly by increasing intracellular calcium 
concentrations which inhibit the activation of adenylate cyclase and the intracellular 
increase in cAMP. The reduction in intracellular cAMP leads to deactivation of 
cholesterol esterase enzymes which are vital for progesterone synthesis. PGF-2a 
also blocks the effects of dibutryl cyclic AMP (Jordan, 1981), a compound capable 
of stimulating the progesterone synthetic pathway but at a step further along the 
pathway from the cAMP site. This would suggest that PGF-2a is also capable of 
inhibiting the synthetic pathway at sites other than the adenylate cyclase-cAMP site.
After the initial PGF-2a release, progesterone begins to decline to baseline. 
Roser et al (1982) reported a significant decline in luteal and plasma progesterone 
concentrations in the mare three hours after treatment with exogenous PGF-2a. Sta- 
benfeldt et al (1981) demonstrated that PGF-2a release preceded the progesterone 
decline by 3-5 hours in the plasma of cycling mares.
The reaction of the luteal cells to the effects of PGF-2a is not consistent 
throughout the lifespan of the CL. In the mare exogenous PGF-2a will not lyse the 
CL until at least Day 4-5 post-ovulation (Allen and Rowson, 1973) and endogenous 
PGF-2a released from the uterus by saline infusion or biopsy does not lead to lysis 
of the CL during early dioestrus (Stabenfeldt et al, 1981). Indeed a stimulatory 
effect of PGF-2a on progesterone secretion has been observed in dispersed cultured 
monkey (Stouffer et al, 1979), human (Richardson, 1987) and bovine luteal cells 
(Benhaim et al, 1981) during the mid luteal phase of the oestrous cycle. However
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these results have not been corroborated by in vivo work. The reason for the refrac­
toriness of the luteal cells during the developmental stages of the cycle has not been 
clarified. Although the number of PGF-2a receptors in the CL of the mare was 
found to vary throughout the oestrous cycle no pattern to the changes was evident 
(Kimball and Wyndegarden, 1977). Increased binding of PGF-2a to its receptor 
site was reported in the bovine during the later stages of the oestrous cycle (Rao et 
al, 1979). Schwall et al (1986) suggested that the large luteal cells which contain 
the PGF-2a receptor sites do not develop until several days after the CL has begun 
functioning and therefore PGF-2oc was not able to bind to the cell membrane and 
exert its effect on progesterone production.
1.11 Prolonged dioestrus
The mare frequently demonstrates a breakdown in the events of luteolysis in 
which lysis of the CL does not occur at the expected time (Stabenfledt et al, 1976). 
The CL will persist in the ovary leading to a state of prolonged dioestrus which, if 
untreated, can last up to 90-100 days. Although prolonged dioestrus has been rec­
ognized in the other species the incidence is very low, 2% in ruminants (Bulman 
and Lamming, 1977) compared to between 20-30% in the mare (Stabenfeldt et al, 
1981: Ginther, 1979). This condition obviously leads to considerable economic loss 
in breeding mares although it can be treated with exogenous PGF-2a, which will 
usually return the mare to standing oestrus within 2-5 days (Allen and Cooper,
1975: Allen et al, 1974).
1.12 Aims of the project
The action of PGF-2a at the CL during luteolysis in the domestic species 
appears to be a complicated interaction of events, with no one event of greater 
importance than the others. Luteolysis in the mare has not been sufficiently investi­
gated and there are many gaps in our understanding of this event in the mare. The 
mare is anatomically and physiologically different from the ruminants in many areas 
of reproduction and therefore the findings reported in these animals cannot be 
extended to the mare. As a result a great deal of investigative work is required to 
fully understand the reproductive cycle of the mare and the events of luteolysis, 
which differ so markedly from that of the ewe and the cow. The purpose of this 
project was therefore to try to assess more accurately the events of luteolysis with
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respect to PGF-2a synthesis, its release from the endometrial and luteal tissue and 
the role that it plays in the events of luteolysis in the mare.
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2 CHAPTER TWO 
BEHAVIOURAL AND CLINICAL STUDIES OF 
FOUR NORMAL CYCLING MARES.
2.1 INTRODUCTION
In the mare many studies have already been undertaken into the behavioural, 
clinical and hormonal changes that occur during the oestrous cycle. However to 
date no obvious detectable changes in any of these parameters have been found 
associated with lysis of the functional corpus luteum.
The aims of the work outlined in this chapter were firstly to gain sufficient 
expertise in the examination of mares using the techniques of teasing by stallion, 
blood sampling for plasma progesterone analysis and examination of the reproduc­
tive tract per rectum, such that the day of ovulation could be accurately assessed. 
Secondly to try to determine if any correlation existed between the fluctuations in 
the width, tone and palpability of the cervix and plasma progesterone concentrations 
during one oestrous cycle. The reason for these studies was to attempt to identify an 
accurate method for determining when luteolysis was occurring in the oestrous 
cycle of the mare.
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2.2 MATERIALS AND METHODS
2.2.1 Mares
Four mares were used in the study. Details of which are outlined in Table
2 :1:
Table 2.1
MARE BREED AGE PREVIOUS
FOALS
Mare 1 Highland X 12 1
Mare 2 New Forest 9 3
Mare 3 Welsh 11 2
Mare 4 Hunter 13 unknown
2.2.2 Behavioural studies
Teasing was carried out daily throughout a complete oestrous cycle in each 
of the mares. Each mare was teased individually, for at least 5 minutes, in the 
presence of an eight year old Welsh pony stallion. Results were recorded using 
the method of Munro et al, (1979), with modifications. The modifications 
involved giving the mare a +/-1 or +/-2 score overall depending on whether the 
individual behavioural responses were exhibited occasionally or continuously, in 
response to the stallion.
2.2.3 Palpation of the genital tract
Palpation of the genital tract per rectum was carried out daily during the oes­
trous cycle of each mare. The mare was restrained in wooden stocks. Ovaries, 
uterus and cervix were palpated. Parameters recorded were: ovarian size and 
consistency; size position and consistency of the largest follicle present on the 
ovaries; cervical size, consistency and state.
2.2.4 Identification of the day of ovulation
The main criterion for determining the day of ovulation was softening of 
the surface of a large mature follicle, followed by loss of this follicular structure 
and a marked reduction in ovarian size. In some of the mares in this group a 
painful response was elicited, on the day of ovulation and in some cases for sev­
eral days after, on palpation of the ovary in which ovulation had occurred. The
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timespan and the degree of response varied between the mares and note was 
taken of the degree of response and the length of time it was elicited.
2.2.5 Examination of the cervix
A measurement of the width of the cervix was obtained by the use of a 
Rectal measuring device (Physics department, University of Exeter). This 
machine consisted of two finger probes, linked to a read-out dial. These probes 
were lubricated well and one was place on the thumb, the other on the second 
finger. They were positioned over the cervix per rectum and the different 
measurements in millimeters were recorded. During examination of the cervix 
observations were also made on the consistency and state of the cervix. The 
scoring system outlined below was used to score each cervix:
0 Very wide flaccid cervix, whose borders could not be accurately 
determined. Width 40-50mm
+ Loss of tension but still formed. Width 30-39mm
++ Closed cervix but little apparent tone. Width 25-29mm
+++ Tightly closed presenting as an obvious ridge. Width < 25mm 
Measurements were taken daily throughout one oestrous cycle in the mares.
2.2.6 Blood sampling regimes
Blood samples were collected daily throughout one oestrous cycle by veni­
puncture from the jugular vein. A 19G 1 1/2" needle (Terumo) and heparinised 
monovets (Sarstedt) were used. Immediately after collection the samples were 
centrifuged (20 mins, 4°C, 2000g) decanted into labelled plastic bottles and 
stored at -20°C until assayed for progesterone concentrations.
2.2.7 Plasma progesterone estimations
Plasma progesterone concentrations were estimated using an established 
radio-immunassay (RIA) procedure as described by Munro et al (1979). The 
intra-assay and inter-assay coefficients were calculated as 13%. The limit of 
sensitivity was 0.5 ng/ml.
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2.3 RESULTS
Figure 2:1 Mare 1
Behavioural, cervical, ovarian and plasma progesterone changes in Mare 1 
during one inter-oestrous period.
Ovulation was recorded in this mare 24 hours before the end of overt oestrus 
when progesterone was basal. A marked painful response was elicited on the day of 
and the day after ovulation in this mare. Throughout the standing oestrous period 
the borders of the cervix could still be readily defined per rectum although some 
loss of tone was apparent. Complete relaxation of the cervix was observed 5 days 
after ovulation when progesterone concentrations were already increasing.
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Figure 2 : 1
Behavioural  changes
^ l l l l
llllllllilllfe;
Size  of largest follicle (cm) 
10
pain
•  •  + t+  +
•  •
Cervical changes
+++
Prog (ng/ml)
ovulation Day of oe s trou s  cycle
Figure 2:2 Mare 2
Behavioural, cervical, ovarian and plasma progesterone changes in Mare 2
during one inter-oestrous period.
Ovulation occurred in this mare 48 hours before the end of overt oestrus. A 
painful response was elicited on the day of ovulation only. A gradual transition 
from behavioural dioestrus to standing oestrus was observed. The cervix gradually 
relaxed 7 days before ovulation to become soft and dilated 2 days prior to ovulation. 
These changes were associated with low progesterone concentrations.
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Figure 2:3 Mare 3
Behavioural, cervical, ovarian and plasma progesterone changes in Mare 3
during one inter-oestrous period.
This mare demonstrated a period of basal progesterone 8-10 days before ovu­
lation, 5 days prior to overt oestrus. Progesterone concentrations increased in the 
plasma 7 days before ovulation but had declined to baseline again 4 days before 
ovulation, the first day of standing oestrus. Ovulation in this mare occurred 24 
hours prior to standing oestrus. A degree of cervical tone was still present during 
the first 3 days of standing oestrus. However the cervix became flaccid and fully 
dilated during the last three days of standing oestrus. No painful response was eli­
cited at any stage in this mare.
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Figure 2:4 Mare 4
Behavioural, cervical, ovarian and plasma progesterone changes in Mare 4
during one inter-oestrous period.
This mare exhibited weak positive behavioural signs during the first two days 
of standing oestrus before full expression of oestrus. Ovulation in this mare 
occurred two days prior to the end of standing oestrus. This mare had a relatively 
relaxed cervix throughout the period of study and the borders were difficult to 
define, although variations were observed. Maximum dilation was recorded during 
the period of standing oestrus. No painful response was elicited on palpation of the 
ovary at any stage in this mare.
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2.4 DISCUSSION
The four mares in this study exhibited negative behaviour during dioestrus and 
positive behaviour during oestrus, although very different patterns of expression 
were observed. Three mares in this group appeared to demonstrate a gradual transi­
tion from dioestrus to standing oestrus. In these mares the decrease in expression of 
negative behaviour appeared to be associated with a drop in progesterone 
concentrations. Although this would suggest a positive correlation between proges­
terone concentration and the intensity of expression, there is no firm evidence to 
date that this is the case. Munro et al (1979) found that variations in plasma 
progesterone concentrations were not correlated to the intensity of negative beha­
vioural expression, although an inverse relationship between plasma progesterone 
concentrations and positive behaviour was recorded by these workers.
Progesterone concentrations declined rapidly at luteolysis in all four mares and 
are therefore one of the most accurate indicators that luteolysis has taken place.
Mare 3 however demonstrated a period of basal progesterone 5 days prior to stand­
ing oestrus. As this is not physiologically likely to happen, it was assumed that 
either blood samples had been muddled or the progesterone assay had recorded 
wrong values. Stabenfeldt et al (1981) demonstrated that PGF-2a release precedes 
progesterone decline by 3-5 hours, therefore if a decline in progesterone concentra­
tions is the only criterion used to determine luteolysis it will be too late to observe 
the luteolytic period. Also, as can be seen from Mare 4, marked fluctuations in 
plasma progesterone concentrations occurred prior to luteolysis therefore it would 
be difficult to predict the luteolytic-associated drop in progesterone concentrations 
by monitoring daily blood samples. It is also time consuming and expensive to 
assay samples on a daily basis to determine fluctuations in the progesterone concen­
trations, and as a result progesterone analysis tends to be retrospective.
During the preliminary clinical investigations one of the main areas of the 
reproductive tract examined per rectum was the cervix. Although previous studies 
of this aspect of the reproductive tract have been undertaken, these were performed 
on a purely clinical basis with no reference to associated progesterone concentra­
tions. In this study clinical findings were related to plasma progesterone concentra­
tions to determine if any correlation existed. Progesterone is the dominant hormone 
of dioestrus and is thought to be responsible for maintaining the cervix in a closed
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state. As progesterone concentrations decline, during luteolysis, it was hypothe­
sized that the cervix of the mare should gradually relax and become less obvious on 
rectal palpation. However the results from this study demonstrated that no 
correlation existed between the plasma progesterone and the cervical fluctuations. 
All four mares demonstrated a closed cervix during mid-dioestrus, although vari­
ations in degree were recorded. In particular Mares 2 and 3 displayed a gradual 
relaxation of the cervix as progesterone concentrations declined during luteolysis, 
suggesting a positive correlation between progesterone concentrations and the cervi­
cal state. Mare 1 however had a palpable cervix throughout the standing oestrous 
period and demonstrated marked dilation of the cervix at Day 5 post-ovulation, 
despite progesterone concentrations of 7ng/ml. Finally Mare 4 demonstrated a rela­
tively relaxed cervix throughout the period of study. Fluctuations in degree were 
observed in this mare but these did not appear to be related to progesterone 
concentrations. The reasons for the fluctuations in cervical size and consistency in 
the mares are not apparent from this study. However factors other than progester­
one may be involved in minor changes in the cervix, for example oestrogen, relaxin 
or possibly prostaglandins, such as PGE-2. None of these other hormones were 
examined during this study therefore it is not possible to determine if changes in 
these hormones could be responsible for the alterations in the cervical states in these 
mares. The results of both the behavioural and cervical studies undertaken in these 
investigations indicated that neither was useful in identifying when luteolysis was 
taking place. The most accurate means of identifying luteolysis in the studies 
described in this thesis was by determining when ovulation took place and presum­
ing that luteolysis would occur around 14 days later.
It is relatively easy to palpate follicles developing on the surface of the 
ovaries. Any changes can be readily monitored and with experience it is possible to 
determine when ovulation of a follicle takes place. Once experience has been 
gained this is one of the most reliable guides to events in the oestrous cycle of the 
mare. Ovulation can be pin-pointed and luteolysis can then be estimated by counting 
forward 14 days. The projected date will only be an estimate of the time of luteoly­
sis as Day 14 is only an average. This is demonstrated by the fact that two of the 
mares in this study exhibited a drop in progesterone at Day 14 post-ovulation 
(Mares 1 and 4) while the other two mares demonstrated a drop in progesterone on 
Day 15 post-ovulation (Mares 2 and 3). All the mares ovulated during the period of
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study and their follicles attained a significant size prior to ovulation. Both Mares 1 
and 2 demonstrated a painful response in the ovary on the day of and the day after 
ovulation. This response is thought to be due to palpation of a newly formed corpus 
haemorragicum in the ovary. Although all mares do not exhibit this reaction it is a 
useful additional parameter for determining the time of ovulation when present.
It is obvious from the above studies that luteolysis is not overtly expressed 
and, if each of the parameters discussed are taken in isolation, it is very difficult to 
assess accurately this stage of the cycle. However if all the parameters are assessed 
together a more accurate picture is obtained. Throughout the period of these 
studies, teasing of the mare was continued as a means of identifying when the mare 
came into standing oestrus. The mares were examined per rectum three times a 
week until behavioural oestrus, when rectal palpation was increased to daily exam­
ination, to try to assess the day of ovulation. Note was also made of any painful 
reactions elicited. The studies of cervical changes were discontinued as no useful 
information was available from the results. The onset of luteolysis was then esti­
mated by counting forward from the day of ovulation to 14 days. Estimations of 
progesterone concentrations in daily blood samples continued to be carried out as 
they formed an essential part of the further investigations. These investigations 
were carried out in all the mares involved in the study.
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3 CHAPTER THREE 
PLASMA PROSTAGLANDIN F-2oc METABOLITE AND PROGESTERONE 
CONCENTRATIONS IN CYCLING MARES AND MARES IN PROLONGED
DIOESTRUS.
3.1 INTRODUCTION
The aims of this chapter were firstly to establish an adequate method of 
measuring 15 keto-13,14 dihydroprostaglandin F-2a (PGFM) and prostaglandin 
F-2a (PGF-2a) concentrations in the circulating plasma of the mares involved in 
this study. Secondly to determine the pattern of PGFM in the plasma of normal 
cycling mares during the period of luteolysis. Thirdly to determine the PGFM pat­
terns in mares in prolonged dioestrus and to compare these patterns to the normal 
cycling mares. Fourthly to manipulate the mares in prolonged dioestrus back into 
standing oestrus by performing uterine biopsies. Finally to determine the effects of 
exogenous PGF-2a on the circulating plasma PGFM, progesterone and PGF-2a 
concentrations in normal cycling mares.
The radio-immunassay (RIA) method used for PGFM estimation in this study 
was that of Dobson (1983) with modifications by Escreet (1986). However several 
problems were encountered involving: the sensitivity of the assay; the percentage 
binding of the radio-active label and the repeatability of the standard curve. A 
reproducible RIA for identifying changes in the PGFM pattern in the plasma was 
defined. The modifications made to the original assay and the comparative results 
of the different assay methods are described and discussed. A second RIA to deter­
mine PGF-2a concentrations in the plasma and in culture medium from tissue 
samples was established and is also described and discussed.
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3.2 MATERIALS AND METHODS
3.2.1 Mares
13 mares were used for the study. All the mares were bled during the nor­
mal breeding season. 11 of the mares were cycling normally prior to the study, 
although 1 mare failed to return to standing oestrus at the expected time and 
entered a phase of prolonged dioestrus. 2 of the mares were in a state of pro­
longed dioestrus prior to the start of the blood sampling regime. Details of the 
mares are given in Table 3:1.
Table 3:1
MARE BREED AGE
(years)
PREVIOUS
FOALS
1 NEW
FOREST
20 several
2 EXMOOR 12 2
3 TB 12 3
4 WELSH 10 unknown
5 TB 10 2
6 TB 12 3
7 TB 15 several
8 DARTMOOR 14 2
9 ARAB X 14 several
10 ARAB X 14 several
11 NEW
FOREST
10 2
12 WELSH 9 unknown
13 TB 17 several
3.2.2 Blood sampling regimes
The mares were divided into three groups:
1) Normal mares (8)
2) Mares in prolonged dioestrus (3)
3) Mares injected with ’Lutalyse’ (2)
The details of each group are outlined below:-
Group 1: Normal cycling mares.
8 mares cycled normally throughout the sampling period and were subdi­
vided into 3 small groups.
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Group la
During October 1985 two mares (Mares 1 and 2) were bled twice daily 
from standing oestrus until Day 13 post ovulation when sampling was increased 
to four times daily, for a period of 4 days in Mare 1 and until standing oestrus in 
Mare 2.
Blood samples were collected from these two mares by venipuncture 
from the jugular vein using a 19G, 11/2" needle (Terumo) and heparinised 
Mono vets (Sarstedt). Immediately after collection the samples were centrifuged 
(20 minutes, 4°C, 1200g), decanted into labelled plastic bottles and stored at 
-20°C until assayed. Mare 5 was also bled by this method.
Group lb
During early September 1986 two mares (Mares 3 and 4) had blood 
samples taken every hour at what was calculated to be Day 13 post ovulation. 
Blood sampling started at 09.00 hours on the day designated Day 13 post ovula­
tion. Due to the cannulae becoming blocked blood sampling was stopped after 
28 hours in Mare 3 and 32 hours in Mare 4.
Group lc
During the month of May 1987 3 mares (Mares 6 ,7  and 8) were bled 
every hour for 57 hours. Mare 5 was bled every 3 hours for 57 hours. Blood 
sampling started at 09.00 hours on the day designated as Day 13 post ovulation.
Blood samples were collected from the jugular vein using a 19G 
(Terumo) indwelling cannula and heparinised monovets in the mares in Groups 
lb  and lc, except Mare 5. The cannulae were stitched into place and patency 
was maintained by heparinised saline washes. Immediately after collection the 
samples were centrifuged (20 mins, 4°C, 1200G), decanted into labelled plastic 
bottles and stored at -20°C until assayed.
35
Group 2 : Mares in prolonged dioestrus
There were three mares in this group. Two of the mares were diag­
nosed as being in a state of prolonged dioestrus prior to the start of blood sampl­
ing. The third mare was cycling normally at the start of the investigations but 
failed to return to standing oestrus at the expected time. This mare remained in 
prolonged dioestrus for a further 3 months.
The bleeding regimes varied in each of these mares.
Mare 9: This mare was blood sampled twice daily, increasing to 4 times daily for 
a period of 4 days. Blood sampling started at Day 45 post-ovulation and 
occurred during October 1985. Day 45 was selected randomly.
Mare 10: this mare was blood sampled hourly for 28 hours starting at Day 13 
post-ovulation during September 1986.
Mare 11: This mare was blood sampled hourly for 57 hours, starting at Day 55 
post-ovulation during May 1987. Day 55 was selected as this would correspond 
approximately to Day 13 post-ovulation of the third oestrous cycle if a 21 day 
oestrous cycle is assumed.
Mares 9 and 11 returned to standing oestrus after an uterine biopsy was taken.
Group 3: Mares injected with ’Lutalyse’
Two mares (Mares 12 and 13) received a 1ml intramuscular injection of 
prostaglandin analog, ’Lutalyse’ (5mg/ml) (Upjohn, Ltd). Indwelling cannulae 
were sutured into place as described above and blood samples were taken every 
10 minutes for 30 minutes prior to the injection, then every 5 minutes for 45 
minutes immediately after the injection. This was decreased to every 15 minutes 
for a further hour. A further 2 samples were taken at 4 and 5 hours post injec­
tion.
3.2.3 Uterine biopsy technique.
The mare was restrained in stocks. The perineum was washed with 
warm water and hibitane. The biopsy instrument was lubricated with Lubrel and 
inserted through the vulvar lips. The cervix was located and the instrument was 
passed gently into the uterus. The position of the instrument was identified digi­
tally per rectum. The cutting edge of the biopsy instrument was placed against
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the roof of the uterus and against the hand in the rectum. A small piece of 
endometrium was removed, placed into Bouin’s fixative and stained by H and E.
Blood samples were collected prior to and following biopsy: Mare 9 had 
blood samples taken 4 times daily until she returned to standing oestrus. The 
samples were collected by venipuncture from the jugular vein. Mare 11 had an 
indwelling cannula sutured into place as described above and blood samples 
were taken every 15 minutes for one hour prior to biopsy. Sampling was 
increased to every 10 minutes for a period of 3 hours after the biopsy had been 
taken. Samples were taken every hour for 5 hours after this.
3.2.4 Teasing
as for Chapter 2.
3.2.5 Palpation of the genital tract per rectum
as for Chapter 2.
3.2.6 Plasma progesterone estimations
Plasma progesterone concentrations were estimated as for Chapter 2.
3.2.7 Estimation of 15 keto 13,14 dihydro prostaglandin F-2a (PGFM)
The method outlined below was that of Dobson (1983) with modifica­
tions by Escreet (1986)
Materials and Methods
1) Assay buffers
0.05M Tris-HCL (pH 7.0) was made up by mixing: 250ml 0.2M Tris 
(hydroxymethyl) methylamine (BDH Chemicals, Poole, Dorset.) (24.23g 
TrisAitre H20 ) and 450ml 0.1M Hydrochloric acid (4.364ml conc. HCL/500ml 
H20 ) and O.lg sodium merthiolate. Water was added to make the volume up to 1 
litre. Tris or HCL was added as necessary to adjust the pH to 7.0.
0.05M Tris-HCL-gel (pH 7.0) was made up by adding: lg  of gelatin to 1 
litre 0.05M Tris-HCL (pH 7.0). The gelatin was dissolved by adding lg  of gela­
tin to a small quantity of Tris HCL and heating until dissolved. This solution 
was then added to the remainder of the Tris HCL and pH adjusted to 7.0 if 
necessary. The buffer solutions were stored at 4°C.
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2) Radioactive Label.
15-keto 13,14 dihydro [5,6,8,9,ll,12,14,(n)-3H] Prostaglandin F-2a (Amersham 
International pic, White lion road Amersham.) Specific activity 80 Ci/mmol.
An intermediate solution of radioactive label was prepared by dissolving 
25uCi of freeze dried label in 20ml ethanol. This was stored at -20°C in a glass 
stoppered flask. A working solution was prepared by drying down 300ul at 
50°C under a stream of air, adding 7.5ml Tris HCL gel buffer and vortex mixing 
to provide 4000c.p.m. in lOOul. This working solution was prepared fresh for 
each assay.
3) Antiserum.
Prostaglandin antiserum was a gift from Dr M.D. Mitchell (Univ. Texas S.W. 
Medical School, Dallas, Texas).
lmg freeze-dried antiserum was reconstituted with 5ml Tris-HCL-gel 
buffer to provide an intermediate dilution of 1:400. This was divided into 400ul 
aliquots and stored at -20°C. A working solution at a dilution of 1:8000 was pre­
pared fresh for each assay by diluting one 400ul aliquot of intermediate solution 
with 7.6ml Tris-HCL-gel buffer.
The concentration of the working solution had previously been calculated as that 
which bound approximately 40% of the3H-PGFM. (Escreet, 1986)
4) PGFM-free plasma (Blank plasma).
Blank plasma was prepared by obtaining plasma from a gelding which 
was assumed to contain negligible quantities of PGFM (Barnes et al, 1978).
This plasma was heated in a water bath at 45°C for 30 minutes, then stored at 
-20°C.
5) Standards.
A stock solution (lug/ml) of PGFM in ethanol was prepared and stored 
at -20°C. 50ul of this solution was dried down at 50°C in a stream of air, then 
dissolved in 10ml of blank plasma. Serial dilutions with blank plasma gave stan­
dards of 2.0, 3.9, 7.8, 15.6, 31.2, 62.5, 125.0 and 250.0pg/100ul. The standard 
solutions were stored at -20°C and made up as necessary.
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6) Controls
Three control plasma samples of high (500pg/ml), medium (250 pg/ml) 
and low (125 pg/ml) values were produced by adding blank plasma to known 
quantities of dried down stock PGFM standard solution. The control samples 
were stored at -20°C.
7) Extraction
The PGFM assay was carried out on unextracted plasma. However the 
samples were heated in a water bath at 45°C for 30 minutes to denature the pro­
tein, prior to incorporation into the assay.
8) Activated charcoal suspension
0.4g methanol-washed activated charcoal (BDH Chemicals, Poole, 
Dorset) was mixed with 80ml Tris-HCL buffer for at least one hour at 4°C prior 
to use. The suspension was made up fresh each week and was stored at 4°C.
9) Scintillation Fluid.
Ecosinct Fluid (National Diagnostics, Unit 3, Chamberlain Rd., Aylesbury, 
Buckinghamshire.)
10) Scintillator Vials.
(Canberra Packard, Brook House, Pangboume, Berkshire.)
11) Assay tubes.
Soda glass 100mm x 16mm
Assay Protocol
The following tubes were set up in duplicate; Total counts (TC): lOOul 
Tris-HCL-gel buffer, Non-specific binding (NSB): lOOul Blank plasma, Total 
binding (Bo): lOOul Blank plasma. Standards: lOOul appropriate standard. Con­
trols: High lOOul high control, Medium 50ul high control + 50ul blank plasma, 
Low 25ul high control + 75ul blank plasma. Unknowns: lOOul unknown 
sample. To all the tubes (except TC and NSB), lOOul of working antiserum sol­
ution was added. To the TC and NSB tubes lOOul Tris-HCL-gel buffer was
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added. All the tubes then received lOOul radioactive label, were vortex mixed 
and incubated at 4°C for between 2 and 24 hours. After incubation 500ul char­
coal suspension was added to all the tubes except the TC tubes which received 
500ul Tris-HCL gel buffer. The charcoal suspension was added to separate the 
antibody-bound PGFM from the free PGFM. All the tubes were vortex mixed, 
incubated at 4°C for 15 minutes, then centrifuged at 1200g;4-8°C for 15 min­
utes. The supernatant, containing the antibody-bound fraction of the PGFM was 
then decanted into the scintillation vials and to each vial was added 2ml of 
scintillant. After thorough mixing the vials were left to equilibrate for at least 10 
minutes. Counting was performed using a Tri-Carb 300C Liquid Scintillation 
System (Canberra Packard, Brook House, Pangboume, Berks.). Results were 
determined by computer using a program based on that of Rodbard and Lewald 
(1970).
Assay Validation
1. Specificity
Cross reactions, calculated by Dr. Mitchell were as follows:
PGFM 100%
15-keto-F-2a 8%
13,14 dihydro F-2a 0.7%
PGF-la; PGE-2a; PGE-1 0.5% (each)
2. Repeatability o f Standard Curve
A composite standard curve (Figure 3:1) from 9 assays indicates that, 
using this method, the standard curve was not highly reproducible. The standard 
deviations are too great for each of the values of standard samples.
3. Precision
The intra-assay coefficient of variation (CV) was calculated using the 
equation:-
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Where x = the mean concentration of randomly selected duplicate pairs 
of samples and the standard deviation (SD) between the duplicate pairs from 9 
assays was calculated using the equation:
d = difference between 2 values of each duplicate pair n = the number of 
duplicate pairs. The intra-assay CV was 24% (n=45) for values < 50pg/ml. The 
inter-assay coefficient was calculated using the equation:
where x = the mean concentration of randomly selected duplicate pairs of 
samples. SD = standard deviation. The inter-assay CV was 37% for a mean 
value of 412pg/ml (3 assays). 34% for mean values of 200pg/ml (9 assays) and 
21% for mean values of 120pg/ml (9 assays).
4. Sensitivity
The limit of sensitivity of the assay, defined as the value at twice the 
standard deviation of blank values, was 6.0pg/tube, equivalent to 60pg/ml at a 
sample volume of lOOul.
5. Accuracy and Parallelism
Accuracy and Parallelism were not calculated for this assay as it was not 
used for the bulk of the work in this chapter.
Authors modifications to the assay described by Escreet
Materials and Methods
1) Assay buffers
The assay buffers used in the modified assay were the same as those in 
the first method except phosphate buffered saline with 1% added bovine serum 
albumin (PBS) was used. Phosphate buffered saline Mix: 4.0g NaCl, 0.1M Na 
H2 P 0 4, 0.1M Na2 H P 04, 0.5g Thiomersal and make up to 5 litres with distilled 
water. Adjust the pH to 7.4.
x
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2) Radio-active label
The intermediate stock solution of radio-active label was made up as in 
the first method. However the working solution was prepared by drying down 
600ul of intermediate stock solution at 50°C under a stream of air and adding 
7.5ml Tris-HCL-gel buffer to provide 8000c.p.m. In lOOul. This volume of 
working solution was prepared fresh for each assay.
3) Antiserum
Prostaglandin antiserum was obtained from Steranti Research Ltd, Lon­
don Rd, St. Albans, Herts, lmg freeze-dried antiserum was reconstituted in 1ml 
Tris-HCL buffer to provide a stock solution at a dilution of 1:100. This was 
stored at -20°C. A working solution was prepared fresh for each assay by adding 
10ml of Tris-HCL buffer to lOOul antiserum stock solution to give a working 
concentration of 1:10,000. The concentration of the working solution was deter­
mined by incubating various dilutions of antiserum with a fixed mass of radio­
active labelled PGFM. The dilution of the working solution was that which 
bound approximately 50% 3H-PGFM (Figure 3:2).
4) PGFM-free plasma (Blank plasma)
Blank plasma was prepared by obtaining plasma from a gelding which 
was assumed to have negligible quantities of PGFM. However to remove all 
PGF-2a and any non-specific binding which may lead to interference, the 
plasma was stripped. The plasma was mixed with lOg unwashed charcoal over­
night at 4°C. The suspension was spun at 1200g for 1 hour and passed through a 
series of millipore filters, 7, 5, 2 and 0.45 um, to remove any remaining charcoal.
5) Standards
The stock solution of standards was as for the first method. 50ul of this 
solution was dried down at 50°C in a stream of air, then dissolved in 10ml PBS 
buffer. Serial dilutions with PBS buffer gave standards of 2.0, 3.9, 7.8,15.6, 
31.2, 62.5, 125.0 and 250.0pg/100ul. The standard solutions were stored at 
-20°Cand made up as necessary.
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6) Controls
Three controls of high (500pg/ml), medium (250pg/ml) and low values 
(125pg/ml) were produced by adding PBS buffer to known quantities of dried- 
down stock PGFM standard solution. The controls were stored at -20°C.
7) Extraction
Extraction was carried out by adding 2ml diethyl ether to the unknown 
plasma samples. The samples and controls were vortex mixed for 10 minutes 
and spun down at 1200g for 15 minutes. The pellet was frozen by immersing the 
tube into methanol containing cardice and the supernatant was decanted into 
fresh assay tubes. The supernatant was dried down in a stream of air at 50°C and 
the tubes included in the assay procedure.
Percentage extraction was calculated by setting up 2 assay tubes with 
20ul working radio-active label added to lOOul PBS buffer. This was vortexed 
for 10 seconds and incubated at room temperature for 30 minutes. Ether extrac­
tion, as described above was carried out on the tubes. No radio-active label or 
antibody was added and the tubes did not undergo the separation procedure. 
1.1ml tris-HCL-gel buffer was added to the assay tubes.
Assay Protocol
The following tubes were set up in duplicate; Total counts (TC): lOOul 
PBS buffer, Non-specific binding (NSB): lOOul PBS buffer, Total binding (Bo): 
lOOul PBS buffer, Percentage Extraction (EXT): as above. Standards: lOOul 
appropriate standard
Controls: High lOOul high control, Medium lOOul medium control and Low 
lOOul low control. Unknowns: lOOul unknown sample. The plasma of all the 
unknown samples was extracted as described above. The assay procedure was 
then the same as that of the first method except the incubation time of the 
samples, antiserum and radio-active label was increased from 2-24 hours to 
30-48 hours.
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Assay Validation
1. Specificity
Cross reactions, calculated by Steranti Ltd., were as follows:
PGFM 100%
15-keto-F-2a 4.2%
PGF-2a; PGF-loc; PGE-2; PGEM; PGE-1
PGA-1; PGA-2; PGB-2; PGD-2; 15-ketoE-2 0.01% (each)
2. Repeatability o f Standard Curve
A composite standard curve (Figure 3:3) from 15 assays indicates that 
the curve was highly reproducible using the modified assay technique.
3. Precision
The intra-assay coefficient of variation calculated as described previ­
ously was calculated to be 4% (n=76) for values <150pg/ml.
The inter-assay coefficient of variation calculated as described previously was 
calculated to be 16% for a mean value of 542pg/ml (15 assays). 18% for mean 
values of 200pg/ml (15 assays) and 14% for mean values of 112pg/ml (15 
assays).
4. Sensitivity
The limit of sensitivity of the assay defined as the value at twice the stan­
dard deviation of blank values was 1.5pg/tube, equivalent to 15pg/ml at a sample 
volume of lOOul.
5. Accuracy
For an assessment of accuracy, known amounts of PGFM (between 
2-250pg/ml) were added to plasma samples and included in several assays.
After adjustment for PGFM concentration pool samples, the mean recovery fig­
ure +/- SEM was 113% +/- 8%.
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6. Parallelism
The standard curve was made up in PBS buffer and a curve of samples, 
measured at different dilutions appeared to be parallel (Figure 3:3).
7. Percentage Extraction
The percentage extraction of the samples was calculated to be 95 +/- 6%.
3.2.8 Prostaglandin F-2a (PGF-2a) estimations
A liquid phase radio-immunassay was established for the determination 
of PGF-2a in the supernatant of incubated tissue samples and in the circulating 
plasma from mares.
1) Assay buffers
i) 0.05M Tris-HCL (pH 7.4) prepared as described for PGFM assay
ii) Tris-HCL-gel buffer (pH 7.4) prepared as described for PGFM assay. 
The buffer solutions were made up as required and stored at -20°C.
2) Radioactive label (tracer).
[5,6,8,9,11,12,14,15,(n-3H) Prostaglandin F-2a (Amersham International pic, 
Amersham, England. Specific activity 160-180 Ci/mmol.
An intermediate solution was prepared by mixing 25uCi of freeze-dried 
label with 25ml ethanol. This stock solution was stored at -20°C. A working 
solution was prepared fresh for each assay by drying down 500ul under a stream 
of air at 50°C. 5ml of Tris-HCL-gel buffer was added to provide 9000cpm in 
50ul.
3) Antiserum.
Prostaglandin F-2a antiserum was donated by Dr. N.L. Poyser, Pharmacology 
Dept., Edinburgh University, Edinburgh, Scotland.
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Aliquots of antiserum, at a dilution of 1:120 were stored at -20°C. A 
working solution was prepared fresh for each assay by adding lOOul of stock sol­
ution to 10ml Tris-HCL-gel buffer to give a final working solution of 1:12,000. 
An antibody dilution curve is demonstrated in Figure 3:4
4) Standards
lmg prostaglandin F-2 a  (Sigma, Poole) was reconstituted with 1ml 
Tris-HCL-gel buffer and stored at -20°C. 41.5ml of Tris-HCL-gel buffer was 
added to 0.1ml of this solution to make up a stock solution which was stored at 
-20°C. A starting concentration of 2400pg/0.1ml was prepared by adding lOOul 
of stock to 10ml Tris-HCL-gel buffer. Serial dilutions with Tris-HCL-gel gave 
the following standards:
S6 2400pg/0.1ml Starting conc.
S5 800pg/0.1ml 1:3 dilution 
S4 267pg/0.1ml 1:9 "
S3 89pg/0.1ml 1:27 "
S2 29.6/0.1 ml 1:81"
SI lOpg/mlO.lml 1:240 "
Standards were stored at -20°C.
5) Controls
Three control samples of high (800pg/ml), medium (400pg/ml) and low 
(200pg/ml) were prepared by adding known quantities of PGF-2a stock to 
DMEM culture medium.
6) Extraction
No extraction was carried out on the samples. The assay was carried out 
directly on the tissue culture medium and the plasma samples. However the tis­
sue culture samples were exposed to three cycles of freezing and thawing by 
placing the sample tubes in liquid nitrogen until frozen followed by immersion in 
warm water until thawed. This disrupted the cell membrane releasing any 
PGF-2a contained within the cells. The cell debris was removed by gentle 
spinning at 500g for 2 minutes.
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7) Separation
Separation of the antibody bound PGF-2a from the free PGF-2a was 
carried out using donkey anti-rabbit IgG precipitating serum and normal rabbit 
serum (SAPU, Carluke, Scotland). A working solution was prepared fresh for 
each assay by adding 0.2ml (1:20 dilution) anti-rabbit serum an 50ul (1:200) nor­
mal rabbit serum, to 5ml Tris-HCL-gel buffer.
8) Scintillation Fluid
As for PGFM assay
9) Scintillation Vials
As for PGFM assay
10) Assay tubes
Plastic LP3 tubes (Luckhams Ltd, Victoria Gdns, Burgess Hill, West 
Sussex).
Assay Protocol
The following tubes were set up in duplicate: Total counts (TC): 0.6ml 
Tris-HCL-gel buffer. Non-specific binding (NSB): 0.6ml Tris-HCL-gel buffer. 
Total binding (Bo): 0.6ml Tris-HCL-gel buffer. Standards: 0.5ml Tris-HCL-gel 
buffer. Controls: High 0.5ml Tris-HCL-gel buffer, Medium 0.5ml Tris-HCL-gel 
buffer and Low 0.5ml Tris-HCL-gel buffer. Unknowns: 0.4ml Tris-HCL-gel 
buffer. To each of the appropriate tubes was added: lOOul of each PGF-2a stan­
dard; the appropriate volume of sample and control to bring the total volume up 
to 0.6ml. To all the tubes 50ul of working tracer was added. All the tubes 
(except TC and NSB) received 50ul of working anti-serum and were mixed thor­
oughly on a vortex mixer. All the tubes were incubated at room temperature for 
a minimum of 60 minutes. After incubation lOOul of the working solution of 
second antibody was added to each of the tubes, except the TC tubes, to separate 
the antibody-bound PGF-2a from the free PGF-2a and the tubes were mixed 
thoroughly using a vortex mixer. All the tubes were then covered and incubated 
for 18-20 hours at 2-8°C. After this second incubation the tubes were centri­
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fuged at 1200g for 30 minutes at 2-8°C- The supernatant of each tube, except 
TC, was decanted and the tubes allowed to drain onto absorbent paper, to 
remove any residual supernatant, leaving a precipitate containing the antibody- 
bound fraction. 1.0ml of 0.1M NaOH was added to all the tubes including the 
TC tubes and the tubes were vortex mixed to dissolve the precipitate. The 
solution was then decanted into scintillation vials and 10-llmls scintillation fluid 
was added to each vial. The vials were then counted in a Tri-Carb 300C Liquid 
Scintillation System. Results were determined using the programme used for the 
PGFM assay.
Assay Validation
7. Specificity
Cross-reactions determined by Dr. Poyser were as follows:
PGF-2oc 100%
PG F-la 100%
PGE-2 1.21%
PGE-1 0.52%
PGA-2 < 0.056%
PGB-2 0.0016%
PGFM 0.56%
PGF-2 0.198%
PGD-2 17.1%
2. Repeatability o f Standard Curve
A composite standard curve (Figure 3:5) from 20 assays indicates that 
the curve was highly reproducible.
3. Precision
The intra-assay coefficient of variation (CV) and the inter-assay CV 
were calculated as for the PGFM assay. The intra-assay CV for this assay was 
calculated at 10% (n = 75). The inter-assay CV was calculated at 16% for a 
standard mean value of 852pg/ml (n = 12), 15% for a standard mean value of 
378pg/ml (n = 12) and 13% for a standard mean value of 218pg/ml (n = 12).
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4 .Sensitivity
The limit of sensitivity of the assay defined as the value at twice the 
standard deviation of blank values, was 8.0pg/tube, equivalent to 40pg/ml at a 
sample volume of 200ul.
5. Accuracy
For an assessment of accuracy, known amounts of PGF-2a (between 
10-240pg/ml) were added to samples and included in several assays. After 
adjustments for PGF-2a concentrations in pool samples the mean recovery fig­
ure +/- SEM was 105% +/- 10%.
6. Parallelism
The standard curve was made up in Tris-HCL-buffer and a curve of 
samples, measured at different dilutions appeared to be parallel (Fig 3:5)
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3.3 RESULTS
The results are presented in two sections. The first deals with the results of 
the experiments to validate the assay developed to measure PGFM. The second 
relates to the measurement of PGFM in the three groups of mares defined in the 
materials and methods.
3.3.1 Assay to determine PGFM 
Table 3:2
Comparisons of PGFM assay method 1 and PGFM assay method 2 after 
modifications were incorporated. The percentage binding in assay method 1 was 
very low. Control values did not determine the correct concentration of PGFM. 
The unknown sample concentration varied markedly between the 2 assay 
methods.
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Table 3:2
PGFM 
ASSAY 
METHOD 1
TOTAL COUNTS (cpm)
PERCENTAGE BINDING 
CONTROL SAMPLE 
VALUES 
HIGH 
MEDIUM 
LOW
UNKNOWN SAMPLE VALUE
(cpm)
1 6
2 5
3 3
4 0
5 0
6 41
7 4
8 0
9 0
10 25
3781
28%
338
876
0
PGFM ASSAY 
METHOD 2
7320
48%
450
225
112
64
44
72
0
32
280
30
18
0
10
56
Table 3:3
Effect of varying the incubation time on the percentage binding. Serial 
assays were set up and incubated for varying times. The percentage binding of 
each was calculated. The optimum binding of 50% was obtained after 46 hours 
incubation.
TIM E (hours) PERCENTAGE BOUND
24
28
30
36
46
47
48 
50 
55
38%
39%
46%
48%
50%
51%
53%
48%
46%
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3.3.2 Group 1 Mares (Normal)
Mare 1 The circulating plasma PGFM and progesterone concentrations 
during one oestrous cycle of Mare 1 are shown in Figure 3:6. As can be seen 
PGFM concentrations fluctuated throughout the sampling period. One signifi­
cant pulse was recorded on Day 15. This pulse occurred after plasma progester­
one had begun to decline, prior to the onset of standing oestrus.
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M are 2 Plasma PGFM concentrations did not rise above 98pg/ml 
throughout the sampling period, although progesterone declined to baseline prior 
to the expression of standing oestrus. [Figure 3:7]
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Mare 3 There was a pulsatile pattern of PGFM release with 4 pulses of 
PGFM observed within the first 14 hours of the sampling period (2 pulses of 
250pg/ml and 2 of lOOpg/ml). Plasma progesterone had already reached base­
line prior to the initiation of blood sampling. The mare returned to standing oes­
trus 4 days after the end of the sampling period. [Figure 3:8]
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M are 4 Two pulses of PGFM were recorded, 21 hours apart. In this 
mare progesterone remained high until after the second large pulse of PGFM 
when progesterone dropped abruptly to baseline. The mare returned to standing 
oestrus 6 days after the end of the sampling period. [Figure 3:9]
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M are 5 This mare was blood sampled once every 3 hours for 57 hours 
starting at Day 13 post-ovulation. Plasma progesterone concentrations declined 
from dioestrous concentrations to baseline during the sampling period. Only one 
PGFM pulse of real significance was recorded in this mare. This was observed 
in the last 24 hours of sampling and occurred after progesterone had declined.
No pulses of PGFM were recorded prior to, or during, the drop in progesterone 
concentrations. This mare returned to standing oestrus 4 days after the end of 
the sampling period. [Figure 3:10]
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Mare 6 Plasma PGFM demonstrated three major pulses, 17 and 15 hours 
apart with several smaller pulses of rapid frequency. [Figure 3:11] The final 
pulse of PGFM was the largest pulse recorded. Progesterone concentrations 
dropped markedly 12 hours after the first pulse of PGFM and continued to drop 
to baseline during the rapid pulsatile PGFM release. The mare returned to stand­
ing oestrus 4 days after the end of the sampling period.
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M are 7 One large pulse of PGFM (183 pg/ml) was followed by a series 
of smaller but rapid pulses. [Figure 3:12] During this pulsatile release a decline 
in progesterone was observed. Progesterone appeared to recover after this but 
dropped rapidly to baseline as further pulses of PGFM occurred. The mare 
returned to standing oestrus 4 days after the end of the sampling period.
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Mare 8  Pulses of PGFM were not observed to increase above 70 pg/ml 
in this mare. Progesterone remained high throughout the sampling period. [Fi­
gure 3:131 This mare returned to standing oestrus 6 days after the end of the 
sampling period.
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3.3.3 Group 2 Mares (Prolonged dioestrus)
M are 9 Two pulses of PGFM were observed during the sampling period, 
starting at Day 45 post-ovulation in a mare in prolonged dioestrus. [Figure 
3:14] The pulses did not exceed 150 pg/ml and were not associated with a drop 
in progesterone concentrations. On Day 62 post-ovulation a uterine biopsy was 
taken and the mare returned to standing oestrus 5 days after the biopsy had been 
taken. No significant pulses of PGFM were detected in the plasma after the 
biopsy.
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Mare 10 Two pulses of PGFM 8 hours apart were recorded during the 
sampling period, in a mare which had been cycling normally prior to the start of 
the study. [Figure 3:15] Neither of the pulses reached a magnitude greater than 
180pg/ml. The second pulse appeared to be associated with a slight decrease in 
progesterone concentrations which did not reach baseline. This mare remained 
in a state of prolonged dioestrus for a period of 3 months before returning spon­
taneously to standing oestrus.
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Mare 11 The circulating plasma progesterone and PGFM during a 57 
hour sampling period is shown in Figure 3:16. Mare 11 had not demonstrated 
standing oestrus for 55 days prior to the start of the bleeding programme. PGFM 
was not observed to increase markedly in this mare throughout the sampling 
period. A series of very small but rapid pulses were detected during the final 24 
hours of sampling. The largest pulse was 90 pg/ml and this appeared to persist 
for over one hour. During this period of increased PGFM release, progesterone 
appeared to be slightly depressed but did not reach baseline and the mare did not 
return to standing oestrus until after a uterine biopsy was taken. Timed blood 
samples were taken before and after the biopsy. Results are demonstrated in Fig­
ure 3:17. No significant pulses of PGFM were recorded during the sampling 
period, the largest pulse recorded was 93pg/ml. Progesterone concentrations did 
not drop during the sampling period but the mare returned to standing oestrus 4 
days after the biopsy was taken.
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3.3.4 Group 3 Mares (Injected with ’Lutalyse’)
Mare 12 Raised plasma PGFM levels were observed in the plasma 10 minutes 
after the injection of ’Lutalyse’ in Mare 12 [Figure 3:18]. The compound dem­
onstrated a triphasic pattern in the plasma, with the three peaks all occurring 
within one and a half hours of the injection. Plasma PGF-2a concentrations 
mimicked the pattern of PGFM. An increase in PGF-2a was first observed 10 
minutes after the injection, the same time as the PGFM increased. The magni­
tude of the PGF-2a peaks was not as great as those of the PGFM pulses and 
progesterone did not decrease during the sampling period. Progesterone 
concentrations remained high throughout the sampling period, although the mare 
returned to standing oestrus 3 days after the injection.
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M are 13 PGFM increased in the plasma 10 minutes after the injection of ’Luta­
lyse’ and rapidly reached a peak of 8 ng/ml at 30 minutes after the injection [Fi­
gure 3:19]. PGF-2a concentrations increased in the plasma to reach a gradual 
peak of 1 ng/ml 35 minutes after the injection. PGF-2a was still elevated in this 
mare up to 2 hours after the injection. Progesterone did not decline during the 
sampling period. Progesterone concentrations remained high throughout the 
sampling period although this mare returned to standing oestrus 3 days later.
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3.4 DISCUSSION
The major findings in this chapter were that adequate methods for the estima­
tions of PGFM and PGF-2a in the circulating plasma of mares had been established. 
These methods were then used to detect a pulsatile pattern of PGFM in the plasma 
of eight normal cycling mares (Group 1) at Day 14 post-ovulation. This pulsatile 
pattern appeared to be associated with a drop in progesterone concentrations and the 
return to standing oestrus. There were three mares that remained in prolonged 
dioestrus (Group 2). Two of this group returned to standing oestrus after an uterine 
biopsy was taken. In two normal cycling mares given exogenous prostaglandin, 
raised PGF-2a concentrations in the plasma were detected despite the very short 
half-life of this compound.
The results in Table 3:2 indicate clearly that the first PGFM assay method 
was not measuring accurately the PGFM concentrations present in the plasma and 
control samples. In an attempt to try to solve these problems and allow a relatively 
accurate assessment of PGFM quantities in the plasma various changes to the assay 
were made.
Initially new radioactive label and antiserum were purchased in an attempt to 
increase the percentage binding. Although this only resulted in a slight improve­
ment it was evident that the label, even when stored at -20°C, had to be purchased 
fresh every two months, if a drop in the percentage binding of the assay was to be 
avoided.
Some workers have increased the sensitivity of assays by decreasing the 
amount of radioactive label added to the samples. Alterations were made to the 
amount of label in this assay but optimum binding was found using 8000cpm. This 
was a slight increase in the concentration of working solution of label used in the 
original assay. In a further attempt to increase the percentage binding prior incuba­
tion of the samples with antiserum alone was investigated. The periods of incuba­
tion varied between one hour and overnight. In addition incubation was carried out 
at either 4°C or room temperature . No appreciable difference in percentage binding 
was found using any of these methods. This may be due to the fact that PGF-2a is a 
relatively small compound and pre-incubation with antiserum does not always 
increase the binding percentage when small compounds are involved. Therefore no 
prior incubation with antiserum was used.
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After carrying out several assays using the first assay method an unexplained 
discrepancy was found between the cpm in the unknown samples, standards and 
total binding (Bo) samples. The unknown samples and the standards were reasona­
bly high but the total binding (Bo) values were inexplicably low. Although this dis­
crepancy is not fully understood it was thought that the unknown samples and 
standard samples may be reaching equilibrium before the total binding samples and 
so a greater incubation time was incorporated into the assay to allow the total bind­
ing values to reach equilibrium. The incubation time with both antiserum and radio­
active label added to the sample was increased from 2-24 hours to 30-48 hours. 
Serial assays were set up and incubated for varying times. The results (Table 3:3) 
demonstrated that the optimum incubation period was 46 hours when 50% of the 
radioactive label was bound. However when compared with 48% bound after only 
30 hours it was felt that the 16 hours delay required to gain an improvement of 2% 
binding was not sufficient to warrant the longer period of incubation. Thus in 
subsequent assays an incubation period of 30 hours was adopted.
According to McLaren et al (1985) a more reproducible standard curve could 
be obtained by making up the standard curve in phosphate buffered saline with 
added bovine serum albumen (PBS). The bovine serum albumen is required in the 
buffer as the protein will stop the PGFM from adhering to assay tubes, pipette tips 
etc. The total binding (Bo), non-specific binding (NSB) and control samples were 
also made up in this buffer. The results (Figure 3:4) demonstrate that the standard 
curve in PBS was comparable to that in stripped plasma and so PBS buffer was used 
in the assay instead of blank plasma.
An attempt was also made to improve the separation procedure using a 
double antibody method. This however was unsuccessful and the separation was 
performed using the charcoal method outlined above.
All the changes adopted greatly improved the efficiency and the sensitivity of 
the assay. However problems did still arise occasionally and the percentage binding 
would drop for no apparent reason. This would then correct itself despite all the 
ingredients being the same. No explicable reason can be given for these fluctu­
ations, although other workers have experienced the same problems with prosta­
glandin assays (McLaren Per Comm)
In retrospect it now seems that it may have been possible to further increase 
the sensitivity and reproducibility of the assay in a number of ways:
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1) Increasing the sample volume from lOOul to 200ul may have helped to resolve 
variability.
2) Increasing the volume of scintillation fluid; the 2mls used in the assay may have 
been insufficient for the sample volume used.
3) Maintaining the samples at 4°C throughout the separation procedure: vortex mix­
ing of the samples was carried out at room temperature and a variable degree of 
warming may have occurred at this stage.
These additional modifications may have increased the sensitivity even 
further and resulted in a better inter-assay coefficient. However as only the trend of 
the PGFM pattern in the plasma and not the actual values were being monitored in 
this study the results demonstrated the expected trend in the mares, despite the dis­
crepancies in the assay.
The PGF-2a assay raised few additional problems to those encountered in the 
PGFM assay. However when the ecosinct fluid was added to the samples fre­
quently not all the sample would go into solution leaving white deposits which 
interfered with the counting of the samples. Therefore lOmls of scintillation 
fluidwere added to the sample, shaken and checked to determine if all the sample 
had dispersed. If not, a further 1ml was added. This volume proved to be adequate.
In the two mares in Group la  (Mares 1 and 2) which had blood samples taken 
every 6 hours at what was calculated to be Day 13 post-ovulation, no clear pattern 
of PGFM was detected. Mare 1 (Fig 3:6) did demonstrate an increase in plasma 
PGFM concentrations at Day 15 post-ovulation. However progesterone concentra­
tions had already begun to decline to baseline prior to the apparent PGFM release, 
suggesting that luteolysis had begun before the pulses of PGFM were observed in 
the blood samples. In Mare 2 (Fig 3:7) no pulses of PGFM were observed despite 
progesterone declining to baseline. However in this mare the circulating plasma 
progesterone concentrations suggest that the day of ovulation was miscalculated. 
Ovulation appeared to occur on Day 3. This mare often appeared indifferent to the 
stallion both during dioestrus and during standing oestrus, making it difficult to 
determine if the mare was in standing oestruS and so it is possible that the day of 
ovulation was miscalculated and inadequate blood samples were taken around the 
time of lysis.
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The results from these two mares did demonstrate that the PGFM assay 
identified PGFM pulses in the plasma. The results also clearly demonstrated the 
difficulties involved in pin-pointing the day of luteolysis. The lack of information 
from these two mares was thought to be due to inadequate frequency of blood 
sampling, which led to false information about PGF-2a release in the mare during 
luteolysis. These findings are in agreement with Kindahl etal (1981) who suggested 
that blood samples had to be taken at least every hour before the true pattern of 
PGFM in the plasma could be observed. Although Neely et al (1979a) had sug­
gested that 6 hourly blood sampling was adequate to determine the pattern of PGFM 
release during luteolysis, the results from these two mares suggest that a longer 
blood sampling period and more frequent blood samples were required. Stabenfeldt 
et al (1981) stated that luteolysis occurred over a 38 hour period. Therefore in 
Group lb two normal mares (Mares 3 and 4) were blood sampled hourly during the 
expected time of luteolysis. Initially it was hoped to take blood samples over a 38 
hour period but both mares lost the function of the cannula and blood sampling had 
to be stopped before the 38 hour period was complete.
Finally in four normal mares (Mares 5, 6 , 7 and 8) in Group lc the blood 
sampling period was increased to 57 hours to ensure that the period of luteolysis 
was fully covered. Mare 5 (Fig 3:10) was bled only every 3 hours, to determine if a 
longer period was adequate to demonstrate the PGFM pattern. Although pulses of 
PGFM were demonstrated in this mare the samples did not appear to give an accu­
rate picture of the PGFM pattern in the plasma. This result confirmed the previous 
hypothesis that animals need to be bled at least every hour over the period of 
luteolysis before the pattern of PGFM in the plasma is revealed.
The results from the mares that were bled hourly suggest a pattern of 
increased PGFM release around Day 14-15 post-ovulation. There were several 
rapid pulses of PGFM released over approximately a 38 hour period. PGFM release 
appeared to be initiated in Mares 4, 6 and 7 by one large pulse followed by several 
pulses of smaller magnitude but increased frequency. In Mares 3 and 6 and possibly 
7 this series of pulses appeared to be followed or terminated by the largest pulse of 
PGFM, often several times greater than the other pulses. In the mares which dem­
onstrated a release pattern of PGFM, progesterone began to decline to baseline dur­
ing the period of PGFM release, except Mare 3 which had baseline progesterone at 
the start of the blood sampling period. Luteolysis must have already begun prior to
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Day 13 in this mare. Local conditions of the uterus have been associated with pre­
mature PGF-2a release. Animals with sub-acute endometritis can have shortened 
interoestrous periods. This effect is thought to be mediated by PGF-2a, released 
from the inflamed endometrium (Stabenfeldt et al, 1976). However Mare 3 demon­
strated no signs of a uterine infection therefore it seems likely that the day of ovula­
tion was again miscalculated in this mare and she was not at Day 13 as expected 
when blood sampling started. This was also thought to be the case in Mare 8 which 
demonstrated no drop in progesterone during the blood sampling period. These two 
mares, along with Mare 2 demonstrate the considerable problems associated with 
trying to pin-point accurately the time of luteolysis in the mare.
In Mares 4, 6 and 7 the first large pulse of PGFM preceded the drop in 
plasma progesterone concentrations by several hours. In Mare 4 the progesterone 
drop appeared to be associated with the second pulse of PGFM. This latter pattern 
agrees with Neely et al (1979a) who reported that the first pulse of PGFM initiated 
luteolysis but preceded the drop in progesterone by 3-5 hours. Only after progester­
one concentrations had declined significantly was the largest pulse of PGFM 
recorded. Poyser (1981) suggested a negative feedback effect of progesterone on 
PGF-2a release and only when progesterone had reached a threshold level could 
PGF-2a be released in a large pulse. This may be a protection mechanism to pro­
tect the CL from slight releases of PGF-2a leading to premature onset of luteolysis. 
These results agree with those of other workers who demonstrated a complex 
pulsatile pattern of PGFM at the expected time of luteolysis in the mare and the 
other domestic species (Neely etal, 1979; McCracken etal, 1981). These workers 
suggested that PGF-2a release at this time was involved in the initiation and com­
pletion of luteolysis and that the pulsatile pattern of release was vital to the outcome 
of luteolysis. However 3 of the mares in Group lc examined did not conform to this 
pattern of PGFM release. At the start of the investigation one of the mares (Mare 
10) was cycling normally whilst the other two (Mares 9 and 11) were already in 
prolonged dioestrus.
Spontaneous persistence of the CL, or prolonged dioestrus is relatively com­
mon in the mare and is one of the major causes of infertility in the breeding mare 
(Stabenfeldt et al, 1974). Stabenfeldt et al, (1981) quoted the incidence at about 
20% although Ginther (1979) reported an incidence of 33% in Thoroughbred mares. 
This is in direct contrast to the other species, particularly the ruminant in which the
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incidence is as low as 2% (Bulman and Lamming, 1977). In the mare the CL 
can persist in the ovary for periods varying between 30-90 days. However the cause of 
prolonged dioestrus is not yet fully understood. Extensive damage to the uterine 
endometrium, where the endometrium is totally destroyed, can impair the synthesis and 
release of PGF-2a and the mare enters a period of prolonged dioestrus (Hughes et al, 
1979). However pyometra due to p haemolytic streptococcus will lead to shortened 
interoestrus periods due to the irritant effect on the uterine endometrium.
A recognized approach to mares in prolonged dioestrus is to perform a uterine 
biopsy which results in the mare returning to standing oestrus within 2-5 days. It was 
decided to adopt this approach to the two mares already in prolonged dioestrus (Mares 
9 and 11) and this had the desired effect in that both mares had returned to standing 
oestrus within 5 days after the biopsy. The mechanism responsible for returning mares 
to standing oestrus after a uterine biopsy is not fully understood but is thought to 
involve the release of PGF-2a from the traumatized uterus, leading to lysis of the CL 
and the return to standing oestrus. However although both these mares were in pro­
longed dioestrus raised PGFM concentrations were demonstrated in the plasma prior to 
the biopsy being taken. Mare 9 (Fig 3:14) demonstrated two pulses of PGFM during 
the blood sampling period. Both pulses were of considerable magnitude but neither led 
to a decrease in the circulating plasma progesterone concentrations. This mare had not 
been observed in standing oestrus for a period of 45 days prior to the onset of blood 
sampling. In Mare 11 (Fig 3:16) the pulses of PGFM recorded were not significant, 
only reaching a magnitude of 98pg/ml.
In the remaining mare in prolonged dioestrus (Mare 10), in which no uterine 
biopsy was taken, two pulses of PGFM were identified some 8 hours apart at the 
expected time of lysis. However neither pulse reached a magnitude greater than 
180pg/ml although the second pulse did appear to cause a slight drop in progesterone 
concentrations. This mare, although apparently cycling normally at the start of the 
study, did not return to standing oestrus for a further 3 months. The mare was exam­
ined regularly throughout this period by teasing with a stallion and by palpation per  
rectum. Blood samples were also taken at irregular intervals and plasma progesterone 
concentrations remained above lng/ml so the mare had not entered anoestrus. In this 
mare either the uterus was capable of some but not enough prostaglandin production to 
bring about luteolysis or it was not released in the correct pattern. The other possibility 
is that a vital secondary source of prostaglandin was not
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stimulated during this time in this mare. By three months it is probable that the CL 
came to the end of its effective lifespan and the mare returned to standing oestrus.
In none of these mares in prolonged dioestrus were the pulses of PGFM asso­
ciated with a significant decline in progesterone. These findings are contrary to the 
findings of Stabenfeldt et al (1981) who demonstrated no PGFM concentrations in 
the plasma of mares in prolonged dioestrus unless associated with dioestrous ovula­
tions. Stabenfeldt et al (1981) hypothesized that this condition represented a bio­
chemical cellular defect, rendering the endometrial cells temporarily incapable of 
synthesising PGF-2a. Stull and Evans (1986) were also unable to demonstrate 
release of PGF-2a from endometrial tissue cultured in vitro from mares in pro­
longed dioestrus. The mares described in this thesis were examined per rectum on a 
daily basis and no apparent ovulations took place, therefore the PGFM patterns 
exhibited did not appear to be related to dioestrous ovulations as suggested by Sta­
benfeldt. However in the mares in prolonged dioestrus the overall magnitude of the 
pulses appeared to be reduced, markedly so in Mare 11. In the light of the rapid 
metabolism of PGF-2a and the anatomy of the uterine and ovarian vasculature in 
the mare it would seem likely that to maintain concentrations of unmetabolized 
PGF-2a at the ovary adequate to ensure that luteolysis proceeds as normal the con­
centration of PGF-2a synthesized and released from the uterus must be critical. If 
these concentrations decline below a certain level then the concentrations at the CL 
will be adversely affected and luteolysis will not proceed. However in both the 
mares biopsies in this study no pulses of PGFM were recorded in the plasma during 
the sampling period despite the mares returning to standing oestrus within 5 days of 
the biopsy. In Mare 9, which had blood samples taken only 4 times a day this could 
have been due to infrequent blood sampling. In Mare 11, which had increased fre­
quency of blood sampling, the release of PGF-2a may have occurred after the blood 
sampling ceased and so the pulses were not picked up.
McCracken et al, (1981) demonstrated that it was not the overall amount of 
prostaglandin released that was essential for luteolysis to take place but the fre­
quency of release that was critical. This was confirmed by the findings of Zarco et 
al (1984) who demonstrated that if the frequency was disrupted and the interval 
between the pulses extended in the ewe, the CL was able to recover from each 
attack of PGF-2a, allowing progesterone synthesis to be maintained. It would seem 
that the CL attempts to maintain production of progesterone and it is only if it is
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continually bombarded with pulses of PGF-2a at a regular rate that the CL suc­
cumbs and luteolysis takes place. Therefore in the mares in prolonged dioestrus 
reported here the pattern of PGFM concentrations appeared to be veiy different 
from normal mares and this may have affected the outcome of luteolysis. However 
it is not possible to draw any firm conclusions from the small sample of mares in 
this study.
In Mares 9 and 11 the uterus appeared normal on histological examination, 
suggesting that no abnormality was present in the uterus preventing the synthesis 
and release of PGF-2a. Mares in prolonged dioestrus usually respond to exogenous 
prostaglandins by returning to standing oestrus 2-5 days after the injection (Allen 
and Cooper, 1975: Allen, 1981). The reasons why these mares will respond to 
exogenous prostaglandins and not to endogenous PGF-2a are not clear. To try to 
clarify this point, two mares in Group 3, Mares 12 and 13, were injected with thera­
peutic doses of an analog of PGF-2a, ’Lutalyse’. Both mares demonstrated baseline 
PGFM prior to the injection but in each case PGFM rose dramatically 10 minutes 
after the injection and by 20 minutes the parent compound appeared in the plasma 
and rose to high levels. Due to the very short half-life of the parent compound it is 
not usually evident in the plasma and PGFM is measured as a marker for PGF-2a 
release (Kindahl et al, 1981). However the uptake of PGF-2a by the lungs is an 
active and saturable process, such that, if the system is overloaded with an excessive 
amount of PGF-2oc, the compound cannot be metabolized and so the concentrations 
in the plasma will build up (Poyser, 1981). Therefore it would seem that, in these 
two mares, the injection of ’Lutalyse’ allowed the release of such a massive dose of 
prostaglandin into the plasma that the metabolic pathways were overloaded and 
unmetabolized prostaglandin was able to build up in the plasma to detectable con­
centrations. In both mares PGFM reached greater values than the normal physio­
logical values observed in normal cycling mares at luteolysis. It would seem likely 
therefore that this injection produced such high concentrations of prostaglandin in 
the plasma that the CL was unable to protect itself and lysis occurred. Progesterone 
did not drop to baseline during the sampling period. This finding is consistent with 
the normally cycling mares which demonstrated a lag period between PGFM release 
and the drop in progesterone concentrations. Progesterone must have dropped to 
baseline after the end of the sampling period as the mares returned to standing oes­
trus.
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Although plasma PGFM concentrations give an indication of PGF-2a con­
centrations they give no indication of the source of the PGF-2a. It is possible that in 
normal mares more than one source is stimulated to release PGF-2a during 
luteolysis. In mares in prolonged dioestrus it may be that although the uterus is able 
to synthesize and release PGF-2a the secondary sources of PGF-2a are not stimu­
lated. Evidence has been growing from studies in the human (Shutt et al, 1976) and 
cattle (Shemesh and Hansell, 1975) that sources of PGF-2a other than the uterus 
may play a role in lysis of the CL in cycling mammals. PGF-2a has been demon­
strated in increasing amounts in the ovarian tissue of these species as luteolysis 
approaches. A self-destruct mechanism may be involved in lysis of the CL.
The results from this study demonstrated the problems encountered if blood 
samples are taken too infrequently and the difficulties involved in pin-pointing 
accurately the day of luteolysis in the mare which has such a variable oestrous 
cycle. However a pulsatile pattern of PGFM was observed in the plasma of cycling 
mares around the expected time of luteolysis. The pattern of PGFM associated with 
lysis in the mares in this study was of a large initial pulse of PGFM. This was fol­
lowed by small frequent pulses leading to a drop in progesterone to baseline. Once 
progesterone had dropped significantly the largest pulse of PGFM was observed. 
This appeared to terminate the release of PGFM. The mare returned to standing oes­
trus in 4-5 days after the end of PGFM release.
Some mares however do not return to standing oestrus but remain in a state of 
prolonged dioestrus. In this study these mares were found to exhibit a pulsatile pat­
tern of PGFM in the circulating plasma but due to some fault in the mechanism lysis 
of the CL did not take place. The pattern of release did not correspond to that 
observed in the normal cycling mares and the magnitude of the pulses of PGFM in 
the plasma appeared to be reduced. These findings raised the possibility of a sec­
ondary source of PGF-2a being involved in luteolysis in the mare. It was decided 
therefore that this possibility of a secondary source of prostaglandin in the mare 
should be investigated.
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4 CHAPTER FOUR 
PROSTAGLANDIN F-2a
PRODUCTION BY ENDOMETRIAL 
AND LUTEAL CELLS CULTURED in vitro
4.1 INTRODUCTION
In several species including the pig (Patek and Watson, 1976), the rhesus 
monkey (Balmaceda et al, 1979) and the human (Shutt et al, 1976) it has been 
shown that the CL is capable of PGF-2a synthesis. During luteolysis in these 
species an increased production of PGF-2a by the luteal cells has been demon­
strated. If the CL of the mare had similar capabilities this would abolish the need 
for the systemic transfer of prostaglandin from the uterus to the ovary, preventing 
metabolism of prostaglandin before it reached the ovary.
The aims of this chapter were firstly to investigate if the CL of the mare was 
capable of PGF-2a production and to determine if production was increased around 
the time of luteolysis. Secondly how this luteal PGF-2a production compared to 
that from the uterine endometrium of the same mare. Inhibition of production, to 
determine if PGF-2a concentrations were due to de novo synthesis, was attempted 
by the addition of aspirin. Finally stimulation of PGF-2a production by both luteal 
and endometrial tissues was attempted by adding oxytocin to the incubation 
medium.
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4.2 MATERIALS AND METHODS
4.2.1 Source of luteal and endometrial tissue
Tissue was obtained from mares at the time of slaughter. In most cases 
luteal and endometrial tissue was removed from the same mare. Corpora lutea 
were carefully excised from the ovary, avoiding the surrounding ovarian tissue. 
Slices of approximately 2g each were removed. Endometrial tissue slices of 
about 4g each were removed, avoiding the underlying myometrial layers.
4.2.2 Preservation of tissue
Both endometrial and luteal tissue slices were placed into cryo-tubes 
(Nunc, Life Technologies Inc., Unit 4, Cawley Mill Trading Estate, Longbridge 
Way, Uxbridge), labelled and snap frozen in liquid nitrogen, using the method of 
King and Evans (1987). The time lapse between slaughter of the mare and snap 
freezing of the tissue was never more than 10 minutes.
4.2.3 Fresh and Frozen tissue samples
A very limited supply of fresh tissue became available from a local 
source. Sections of endometrial and luteal tissues were removed from 2 mares 
and stored in liquid nitrogen as described. Further endometrial and luteal sec­
tions were removed and stored on ice. On return to the laboratory these chilled 
sections were processed immediately. The frozen sections were processed at a 
later date and the results of the two were compared.
4.2.4 Determination of the stage of the oestrous cycle
a) Plasma progesterone analysis
Blood samples were taken immediately prior to slaughter and assayed for 
progesterone concentrations as described in Chapter 2. Blood samples were not 
available from the mares which had explant samples removed and so no proges­
terone estimations were possible.
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b) Macroscopic examination o f CL
Macroscopic examination of the CL was undertaken immediately after 
slaughter and the CL grouped into 4 different stages of the oestrous cycle:
STAGE COLOUR
early luteal Very dark red
mid luteal Brown
/red
late luteal Brown
/yellow
follicular Yellow
/orange
CONSISTENCY STATE
Liquid Active
/sticky
Fleshy Active
Firm Active
/fibrous /Inactive
Greasy Inactive
/friable
c) Microscopic examination
Small sections of luteal tissue, about 1cm, were removed from 
each CL. These sections were fixed immediately in Bouins Fixative solution. 
Paraffin sections of tissue samples were prepared and stained with 
Haematoxylin-eosin (H and E) on return to the laboratory.
Sections were examined with a light microscope and microscopic changes in 
appearance of the growing, secreting and degenerating CL noted. The features 
examined were:
1) Appearance and amount of luteal tissue.
2) Appearance of luteal cells
a) size of cells
b) size of nucleus
c) density of staining
d) state of cytoplasm
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leading to determination if luteal cells were active, inactive or degenerating
3) Vascularity of structure
4) Presence and amount of connective tissue
5) Presence and amount of inflammatory cells, particularly eosi­
nophils and macrophages.
The tissue was then categorised into the following groups:
a) Early luteal phase
b) Mid luteal phase
c) Late luteal phase
d) Follicular phase
4.2.5 Tissue culture methods
Two tissue culture methods were used. The medium used throughout was 
Dulbeccos Modified Eagles medium with 4500mg/L glucose and without pyru­
vate (DMEM; Gibco Ltd, Paisley).
a) Explant tissue culture method
Endometrial or luteal tissue was removed from the liquid nitrogen and 
thawed in water at 37°C tissue was then blotted dry and weighed. 10ml DMEM 
at room temperature was added to every one gram of tissue and placed in a glass 
stoppered flask. The medium and tissue were incubated at 37°C for up to 120 
minutes and gassed for 10-20 seconds every hour with a mixture of 95% air and 
5% CO2. Aliquots of 300ul were removed at 0, 30, 60 and 120 minutes, decanted 
into labelled plastic bottles and stored at -20°C until assayed for PGF-2a con­
centration.
b) Single cell suspension method
Endometrial or luteal tissue was removed from liquid nitrogen and thawed 
in water at 37°C as before. The tissue was washed three times in ice-cold 
DMEM, blotted dry and weighed. Using sharp scissors the tissue was minced in 
ice-cold DMEM. The minced tissue was added to a fresh volume of medium in 
a glass flask (10ml of DMEM was added per lg  of tissue). Dispase II (Boeh- 
ringer Mannheim) was added to the medium at a concentration of 2.0U/ml and 
the solution was incubated at 37°C in a shaking incubator for 120 minutes. The 
flask contents were then removed, centrifuged (5 minutes, 500g) and the super­
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natant passed through a single layer of cheese-cloth to remove any residual 
debris. The cheese-cloth was rinsed through with fresh DMEM to remove any 
single cells attached to the cloth. The supernatant was centrifuged again (10 min­
utes, 1200g) and the pellet was washed with fresh DMEM. This step was 
repeated three times. Two millilitres of fresh medium was added to the final 
washed pellet. Cell numbers were determined by Coulter counter. Duplicate 
aliquots of 1 x l03cells/ml were set up as follows:
a) controls: nothing added to the medium
b) oxytocin added to the medium at a final concentration of 
either 0.liu/ml or l.Oiu/ml. Oxytocin was added to determine if 
PGF-2a production from the tissues was stimulated by the addi­
tion of oxytocin and if the effects were dose dependent.
c) aspirin added at a final concentration of lug/ml. Aspirin was 
added to inhibit PGF-2a production and so determine if PGF-2a 
production was due to de novo synthesis.
The aliquots were incubated at 37°C in a shaking incubator and gassed 
with 5% C 02:95% air for 10-20 seconds every hour. 500 ul of the cell suspen­
sion were removed at 0, 30, 60 and 120 minutes, decanted into labelled plastic 
bottles and stored at -20°C until assayed for PGF-2a concentration.
4.2.6 Prostaglandin F-2a (PGF-2a) estimation
PGF-2a estimation was carried out as described in Chapter 3
4.2.7 Statistical analysis
Statistical analysis was carried out using the One Way Analysis of Vari­
ance test. However, as the variability in each of the samples in the different 
groups was not equal, analysis could not be carried out in all cases.
4.2.8 Tissue progesterone estimation
Estimation of progesterone concentrations was carried out on the super­
natant from luteal cells at different stages of the cycle. This assay was not carried 
out in every case due to the lack of sample volume. The assay was carried out as 
in Chapter 2. DMEM culture medium was assayed for progesterone concentra­
tions and found to have zero value. As it was the trend of the results from simi­
lar samples obtained from this assay which were being considered, no
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corrections were made for the samples being in medium and not plasma. Also 
the baseline was considered to be the same as that for samples in plasma.
4.2.9 Identification of viable cells
A sample of cell suspension was mixed with an equal volume of 0.4% 
Trypan Blue in 0.9% saline. Those cells which excluded dye when observed 
under bright field microscopy were considered viable. However this factor was 
not taken into account in the calculations of PGF-2a production by the tissues.
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4.3 RESULTS
Table 4:1
Table 4:1 demonstrates the comparison between the production of 
PGF-2a tissues which were either fresh or frozen prior to culture. In both cases 
examined the frozen tissue results were slightly depressed compared to the fresh 
results.
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Table 4:2
From the results of PGF-2a production by explants of luteal tissue taken 
from various mares at different stages of the oestrous cycle it would appear that 
there was a marked increase in PGF-2a production by the explants from the late 
luteal phase tissues compared to the early/mid luteal phase.
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Table 4:3
It is evident from the results of PGF-2a production by luteal cells in single 
cell suspension from the different stages of the oestrous cycle that there was a 
marked increase in PGF-2a production during the late luteal phase at all incuba­
tion times. This increase was found to be statistically significant (P < 0.01)
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Table 4:4
Table 4:4 demonstrates progesterone production by luteal cells from different 
stages of the oestrous cycle. Most of the cell suspensions released concentra­
tions of progesterone above baseline during early, mid and late luteal phases. 
Concentrations dropped to baseline in all the samples during the follicular 
phase of the cycle.
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Table 4:5
Table 4:5 demonstrates the effects of aspirin on PGF-2a production by luteal 
cells in a single cell suspension at different stages of the oestrous cycle.
In each of the samples aspirin appeared to lead to an inhibition of PGF-2a 
production by the luteal cells. This effect was most marked after 60 minutes incu­
bation.
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Table 4:6
During the early luteal phase explants of endometrial tissue released rela­
tively high concentrations of PGF-2a. Production apparently dropped off towards 
the mid luteal phase. A marked increase in PGF-2a production was then observed 
during the late luteal phase. This increase was greater than the production 
during the early luteal phase.
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Table 4:7
Table 4:7 demonstrates PGF-2a production by endometrial cells in single 
cell suspension. The cells were taken from different areas of the uterus and at 
different stages of the oestrous cycle. Minor fluctuations in production between 
mares and between the different areas of the uterus occurred but these were not 
thought to be significant.
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Table 4:8
During the late luteal phase there was a marked increase in PGF-2a production 
by the endometrial cells in single cell suspension. The concentrations released 
were significantly greater than those released during the early and mid luteal 
phases (P < 0.001)
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Table 4:9
Table 4:9 demonstrates the effects of aspirin on PGF-2a production by 
endometrial cells in single cell suspension at 6 different stages of the oestrous 
cycle.
Aspirin appeared to lead to an inhibition of PGF-2a production from the 
endometrial cells. This effect was most marked after 60 minutes incubation.
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Table 4:10
Table 4:10 compares the production ofPGF-2a released from the luteal 
tissue explants and the endometrial tissue explants.
There appears to belittle variation in production between the two tissue explant 
culture except during the early luteal phase when the endometrial production of 
PGF-2a is significantly raised compared to the luteal prostaglandin production at 
each incubation time.
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Table 4:11
Table 4:11 compares PGF-2a production from single cell suspension cul­
tures of luteal and endometrial tissues.
PGF-2a production by the two tissues appeared to be roughly comparable. 
It does appear as if endometrial production was slightly greater than the 
luteal production especially after 60 minutes incubation during the late luteal phase.
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Table 4:12
In Table 4:12, during the early and late luteal phase, oxytocin appeared to 
exert a slight inhibitory effect on PGF-2a production by luteal tissue explant 
samples. During the early luteal phase at 30 minutes incubation, a marked increase 
in PGF-2a production was observed. This immediately dropped to baseline. 
During the mid luteal phase oxytocin appeared to exert a stimulatory effect on 
PGF-2a production.
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Table 4:13
From this table it would appear that oxytocin did not have any effect on 
PGF-2a production by the luteal cells in single cell suspension at any stage of the 
incubation period.
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Table 4:14
During the early and mid luteal phases oxytocin appeared to exert a slight 
stimulatory effect on PGF-2a production by the endometrial tissue explant 
samples. However an inhibitory effect was observed during the late luteal phase.
126
TA
BL
E 
4:
14
Ef
fe
cts
 o
f 
ox
yt
oc
in
 
(li
u/
m
l) 
on 
PG
F-
2a
 
pr
od
uc
tio
n 
(ng
/g 
tis
su
e)
 b
y 
en
do
m
et
ria
l 
tis
su
e 
ex
pl
an
ts 
re
m
ov
ed
 
fro
m 
ma
res
 a
t 
di
ffe
re
nt
 s
tag
es
 o
f 
th
e 
oe
str
ou
s 
cy
cl
e.
£
ZHH
uo
&
Xo
s
&
OX)
*030c
aCNI
fa
Ofa
Ov cnCN 1—H ooo cn o CNooOv MK. Ov cncn v Nr - ininr - 00 IT^*OV Ov o Ovi-Ht^HCN H^CN N" T"HCN
+1-H+1+i +1+1+1+1 +1+1+1
CN Ov 00OV© VO cn t*HIOCN ooCN r - OO 00 m o M J CslOv CNOv CN Ov OV inocn v Nr - OO
CN VO VOWi-H i"Hcn CN in
cn
CN
+1
CN
OO
CN
fao
fa
Hzo
u
N" o cn r-> oo CN cn VO
cn cn cn m cn cn Ov in
in o vo cn oo CN vo O 'vo cn
CN in cn in CN ^H r—Hi^ H >4fa rt-
+1 +1 +1 +1 +1 +1 +1 +1 +1 +1
cn r-~ CN Ov CN o oo OvSS.1 VOi-H CN VO t*H r - T f Ov vo CN T f
m T-H CN oo CN o cn m t-H OvCN in in r"~ i—H ^H i-H in
invo
+1 +1 
r" vo
Ov VO 
VO CN
o  r -
fa
fa
fa
Uz
cnc o o o gcn o  3_j m vo ^  cnvofa
fa
O
Oz
Wfa
fa
<
2
fafa
2
1/3
cn CN
Wco
+1
r_  CO
°  o  S
1  s  g<  m  r ,H g U
co O
fa
S<fa
Table 4:15
From Table 4:15 it would appear that oxytocin had no marked effect on 
PGF-2a production by the endometrial cells in single cell suspension at any 
stage of the oestrous cycle.
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Table 4:16
The concentrations of PGF-2a released from the tissues demonstrated in Table 
4:16 do not demonstrate a gradual increase in concentrations. No apparent pattern to 
the release can be determined in these samples.
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Plate 4:1
Gross examination Early luteal phase
At this stage the CL consisted primarily of a large blood clot filling almost 
the whole of the ovarian substance (arrow). The structure was pliable when pres­
sure was applied and on sectioning appeared either dark red/brown in colour and 
fluid-filled or dark red with a thick, sticky consistency.
Plates 4:2 and 4:3
Histological examination Early luteal phase
Histological examination demonstrated a lacey and insubstantial appear­
ance to the luteal tissue which was found around the outer edges of the structure 
at this stage. The predominant cell type was a large, pale vacuolated cell 
(arrow). The central cavity full of debris and blood clot was very evident at low 
power and the tissue appeared highly vascular. At high power several large pale 
luteal cells can be seen with numerous blood cells throughout the section.
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Plate 4:2 (Magnification X4)
Plate 4:3 (Magnification X650)
Plate 4:4
Gross examination Mid luteal phase
By the mid luteal phase of the oestrous cycle the CL appeared smaller and 
more compact than the early luteal phase due to a reduction in the central blood 
clot and an increase in the organised luteal tissue. On section the luteal 
tissue appeared red/brown in colour with a firm, fleshy consistency (arrow).
Plates 4:5 and 4:6
Histological examination Mid luteal phase
There appeared to be an increase in the total amount of luteal tissue present 
at this stage due to both hypertrophy and hyperplasia of the luteal cells and a 
reduction in the central cavity. Fine strands of connective tissue were evi­
dent giving the CL alobullated appearance. The structure appeared very 
vascular. The luteal cells were primarily the large, pale vacuolated cells but 
small, dark cells with eosinophillic cytoplasms were evident along the edges of 
the connective tissue strands and along the edges of the CL. The small dark cells 
are readily seen at higher power (arrow).
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Plate 4:4
Plate 4:5 (Magnification X4)
Plate 4:6 (Magnification X650)
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Plate 4:7
Gross examination Late luteal phase
By the late luteal phase of the oestrous cycle the CL appeared as a firm 
red/brown structure embedded in the substance of the ovary (arrow), often with 
an obvious brown tract leading from the CL through the pale ovarian stroma to 
the ovulatory fossa.
Plates 4:8 and 4:9
Histological examination Late luteal phase
Histologically there was an increase in the connective tissue component of 
the CL at this stage producing obvious lobullation. On low power the structure 
had a striated appearance as the cells appeared to radiate towards the centre of the 
gland. Small dark cells were evident throughout the luteal substance (arrow) 
although the majority of the cells appeared to be the large pale cells. There 
appeared to be a marked increase in the intracellular spaces leading to a less 
compact appearance.
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Plate 4:7
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Plate 4:8 (Magnification X4)
Plate 4:9 (Magnification X650)
Plate 4:10
Gross examination Follicular phase
By the follicular phase of the oestrous cycle the regressing CL appeared 
small and yellow/orange in colour with a greasy, fat consistency (arrow).
Plates 4:11 and 4:12
Histological examination Follicular phase
The luteal tissue appeared less dense during this stage due to an increase in 
the intracellular spaces. All the luteal cells appeared small and dark on low power 
with marked evidence of degeneration of the cells. The cells appeared to be full of 
an amorphous substance, thought to be cholesterol stored in the cells for involve­
ment in the synthesis of progesterone. At higher power the cytoplasm of the 
cells appeared shrunken and the nuclei pyknotic (arrow). The overall picture 
was of a dying, degenerating structure.
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Plate 4:10
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Plate 4:11 (Magnification X4)
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Plate 4:12 (Magnification X650)
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4.4 DISCUSSION
To determine if a secondary source of PGF-2a was present in the mare, 
samples of endometrial and luteal tissues were obtained from mares immediately 
after slaughter. To allow transportation of samples from the slaughterhouse 
to the laboratory, a distance of over 200  miles, preservation of the tissue was 
required. The tissue was therefore placed in cryotubes and snap frozen in liquid 
nitrogen. Vernon eta l (1981) had reported satisfactory results from freezing uter­
ine tissue for receptor binding studies and King and Evans (1987) carried out 
snap freezing of endometrial and luteal tissue in liquid nitrogen prior to 
culturing for assessment of PGF-2a production. The results of the comparison 
of PGF-2a production by fresh and frozen tissue from a local source indi­
cated that PGF-2a concentrations released from fresh and frozen tissue were 
comparable (Table 4:1). However it was found that some of the samples gave odd 
results or the tissue released no PGF-2a concentrations at all during the incubation 
period (Table 4:16). This suggested that the tissue was damaged either by the freez­
ing process or by storing it in liquid nitrogen. As tissue was taken from more than 
one site of the uterus or CL, results were obtained from each mare.
The addition of a cryoprotectant to the tissues before freezing, such as 
dimethyl sulfoxide, might have increased preservation of the tissue. A more gradual 
freezing process, taking the temperature of the tissue down to -70°C prior to 
immersion in liquid nitrogen, may have minimised tissue damage due to the 
formation of ice crystals inside the cells. Also the addition of a solution of 
indomethacin in medium to the samples would have inhibited any release of 
prostaglandin from tissues damaged by freezing. However these procedures were 
not adopted in the studies reported.
As no reproductive history of the mares was available, an accurate method 
for determining the stage of the oestrous cycle had to be devised. Van Nier- 
kerk (1973) categorised the CL of the mare by gross and histological changes of the 
CL at different stages of the oestrous cycle. Obviously the ideal method would 
have been to assess the stage of the oestrous cycle in the live mare, cull the mare 
and take various samples at the appropriate stage.
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However in these investigations assessment of the stage of the oestrous cycle 
was determined by:
a) Macroscopic examination of the reproductive tract immediately after 
slaughter
b) Examination of histological sections from CL.
Initial gross examination allowed segregation into active and non-active CL. 
The newly ovulated CL appeared sticky and full of brown, viscous fluid and took 
up a large part of the ovarian substance. The ovary therefore appeared large 
and very soft. This was considered to be the Corpus haemorragicum. With 
increasing organisation the CL appeared red/brown in colour, with a fleshy/firm 
consistency. It appeared more compact and smaller but still occupied a large part 
of the ovary. As the CL aged it appeared increasingly firm and brown. The non­
active CL tended to appear yellow/orange and greasy in consistency. The non­
active CL tended to be smaller in size than the active CL.
Further segregation was carried out by examination of histological sections. 
This allowed segregation into the following categories:
a) Early luteal phase active
b) Mid luteal phase active
c) Late luteal phase active
d) Follicular phase non-active
During the early luteal stage ovulation had occurred relatively recently and 
luteal tissue was beginning to develop around the outer edge of the structure, 
therefore on histological section there appeared a large central area full of blood, 
debris and cells with lacey, insubstantial tissue around the outer edge. At this 
stage of the oestrous cycle the principal luteal cell type was a large, pale-stain­
ing cell with a vacuolated cytoplasm. The tissue was very vascular at this stage 
and there was little connective tissue apparent. By the mid luteal stage the luteal 
tissue had increased leading to a reduction in the central cavity. The luteal cells 
had become more organised with connective tissue strands penetrating the sub­
stance of the CL, leading to lobullation of the structure. Small dark cells had 
begun to appear along the connective tissue tracts. At this stage the tissue was 
still very vascular.
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By the late luteal phase the CL appeared very organised with marked lobulla­
tion of tissue. The cells grew in tracts, leading to a striated appearance in the CL. 
Cell type was primarily large and pale but there was an increase in the numbers of 
small dark cells present. Evidence of degeneration of the luteal cells appeared at this 
stage with an increase in inflammatory cells, primarily macrophages and 
eosinophils.
By the follicular stage of the oestrous cycle luteolysis had taken place and 
the CL appeared as a dead and dying structure. Degenerating cells appeared full 
of fat and there was evidence of phagocytosis by increased numbers of inflamma­
tory cells. Connective tissue was abundant at this stage.
The large pale-staining cells are thought to be the active progesterone 
producers. The vacuolated appearance was due to progesterone, stored in 
the cytoplasm, being washed out during the staining process (Van Nierkerk, 1973). 
They are abundant during the early and mid luteal phases when progesterone 
secretion by the cells is maximal. As the CL ages there is an increase in the 
numbers of small dark cells. Van Nierkerk thought that these cells represented a 
resting stage of the progesterone secretor cells and he reported that by Day 12 
post-ovulation the major cell type of the CL was the small dark cell. In this study 
the numbers of these cells appeared to increase as the CL aged but by the late 
stage the large, pale-staining cells still appeared to be in the majority, although no 
actual count of cells was taken. Van Nierkerk suggested that by Day 14 post-ovu- 
lation the small dark cells did not revert to the pale-staining cells but degenerated. 
Evidence of this was not found in this study as it appeared that prior to 
degeneration the luteal cells became filled with fat, due to a build-up of choles­
terol in the cytoplasm of the cells not synthesising progesterone (Challis et al, 
1976). This build-up of fat led to the greasy, yellow consistency in the older, 
non-active structure. It is possible therefore that the small dark cells are physio­
logically distinct cells from the large pale cells. This would agree with the findings 
in the CL of the ewe, that the two cell types are physiologically distinct 
(O’Shea, 1987). Phagocytosis by the inflammatory cells followed by degener­
ation of the structure was then observed.
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These studies allowed ageing of the various tissues obtained at slaughter 
and gave an indication of the stage of the oestrous cycle, prior to the assessment 
of PGF-2a production by the tissues. However this method of ageing was not 
ideal and some overlap of the stages obviously occurred, leading to inaccuracies 
in the results obtained. However under the conditions available, this 
method was considered to be satisfactory.
The initial attempts to assess PGF-2a production by the CL and endometrial 
tissues of the mares, where explants of tissue were incubated in vitro and assayed 
for PGF-2a production gave inconclusive results (Tables 4:2 and 4:6). However 
the results demonstrated that both the luteal and the endometrial tissue survived 
the freezing process and were capable of PGF-2a production at all stages of the 
oestrous cycle. During the early luteal stage endometrial tissue PGF-2a production 
was relatively high but a marked drop in production was observed during the mid 
luteal stage. Poyser (1981) suggested that progesterone inhibits PGF-2a produc­
tion. The increased release of progesterone during the mid luteal phase, com­
pared to the early luteal phase, may be the reason for the apparent decrease in 
PGF-2a production during the mid luteal phase. No progesterone results were 
available from the explant samples, however the effect was not demonstrated in 
the luteal tissue samples therefore it seems unlikely that the high concentrations 
of PGF-2a in the early luteal phase compared to the mid luteal phase was due to 
this effect. Red blood cells release significant amounts of PGF-2a and it maybe that 
the endometrial tissue had a high percentage of these cells present. However early 
luteal phase luteal tissue should have a high preponderance of red blood cells due to 
the corpus haemorragicum. The other possibility is that the endometrium still 
remains capable of a higher production of PGF-2a during the early luteal phase 
after the previous luteolysis. The other possibilty is that PGF-2a was released in 
response to endometrial tissue damage caused by the freezing and storing of the tis­
sue.
During the late luteal phase there was a marked increase in PGF-2a from CL 
and endometrial tissue after 60 minutes incubation even compared to the early 
luteal phase. This tissue was taken from mares thought to be at the expected 
time of luteolysis and would suggest that an increased production of PGF-2a from 
the endometrium occurred in the mares during luteolysis.
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In an attempt to determine if PGF-2a production by the endometrial and 
luteal explants was due to de novo synthesis from the tissue, indomethacin was 
added to the tissue samples. Indomethacin inhibits PGF-2a synthesis by inhibiting 
the enzyme cyclo-oxygenase, a vital enzyme in the synthetic pathway of PGF-2a 
(Vane, 1971). As prostaglandin is not stored in cells but synthesised and released 
as required, inhibition of the synthetic pathway will give an indication of 
whether or not PGF-2a is being actively synthesised by the cells (Smith and 
Lands, 1971). A concentration of lug indomethacin/ml and lOug indometha- 
cin/ml was added to the incubates. However the indomethacin did not go into 
solution but produced a precipitate. When samples with indomethacin were 
assayed for PGF-2a the concentration of PGF-2a was found to be greatly 
increased compared to the control samples. When the indomethacin was pel­
leted by centrifugation the PGF-2a concentrations declined but not to below con­
trol sample concentrations. An attempt was then made to dissolve the 
indomethacin in a small volume of absolute alcohol before adding to the 
culture. However this again apparently interfered with the assay.
Three standard curves were set up with the addition of:
1) indomethacin
2) indomethacin dissolved in absolute alcohol
3) absolute alcohol
to each of the standards.
In each case a straight line was produced.
Indomethacin is an acknowledged prostaglandin inhibitor and is the drug 
of choice in most in vitro experiments and so should not be capable of stimulating 
PGF-2a production from uterine and luteal tissues. The reason for the apparent 
increase in PGF-2a production was thought to be due to a physical interfer­
ence of the indomethacin and alcohol with the Scintillation counter giving 
unrealistically high counts. The results from the standard curves with 
additional indomethacin and alcohol confirms this hypothesis. However the 
reasons why indomethacin was interfering in the assay remain unclear. Two dif­
ferent batches of indomethacin were tried and each gave the same results there­
fore the effect did not appear to be due to contamination of a batch. No reports 
of this problem could be found in the literature. In an attempt to overcome this 
problem, soluble aspirin was added to the incubates instead of indomethacin.
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Several different concentrations of aspirin were tried but eventually a concen­
tration of lug/ml was found to optimally inhibit PGF-2a production without 
causing any interference in the assay. Soluble aspirin was therefore used 
instead of indomethacin in this study.
To try to determine if the effects observed in the explant samples were 
real or not a single cell suspension culture was established. Initially the study 
set out to investigate if any difference between PGF-2a production from different 
areas of the uterus was apparent. Sections of endometrial tissue were removed 
from both the uterine hom tips, the horns themselves and the uterine body (Table 
4:7). There appeared to be a marked increase in PGF-2a production from the 
right hom of Mare C at 120 minutes incubation but this was thought to be prob­
ably due to an artefactual effect. As the tissue culture method and the PGF-2a 
assay were not accurate enough to allow quantitative comparisons between the 
results obtained and, as no obvious differences between the different areas of 
the uterus were apparent, this part of the study was stopped and only endometrial 
sections from the body of the uterus were taken.
In both endometrial and luteal single cell suspensions (Tables 4:3 and 4:8) 
PGF-2a was released from the cells at all stages of the oestrous cycle with a 
gradual increase in PGF-2a production during the incubation period. A slight 
increase in PGF-2a production was observed between the early and mid luteal 
stages in both luteal and endometrial tissues but this increase was not statistically 
significant. In both the luteal and endometrial tissue samples the standard error 
was high. This effect was thought to be caused by the marked variations in the 
actual PGF-2a values, probably caused by variations in the exact stage of the oes­
trous cycle between the mares and also a natural variation in PGF-2a production 
between the relatively small numbers of mares examined.
During the early and mid luteal phases progesterone concentrations 
increased in the plasma as the CL became fully functional and luteal progester­
one production increased during this period as expected. It appeared therefore that 
when progesterone production was maximal, PGF-2a production by both the 
luteal and endometrial cells was minimal. These results' contrast with the 
explant results. However as the numbers of samples examined was increased in 
the single cell suspension and as this method was more sophisticated, it was
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assumed that these results gave a more accurate picture of PGF-2a release from the 
luteal and endometrial tissues.
During the late luteal stage endometrial and luteal PGF-2a demonstrated a 
marked increase in production compared to the early and mid luteal stages. In 
both the endometrial and luteal samples the increase observed was statistically sig­
nificant (P >0.01 luteal, P >0.001 endometrial). In each case aspirin led to 
inhibition of PGF-2a production, suggesting that the PGF-2a released was due 
to de novo synthesis by the tissues.
During the late luteal phase the standard error was within acceptable 
limits in both the luteal and endometrial samples, suggesting that the actual 
values of PGF-2a released by the cells of individual mares were more consistent.
During the late stage of the oestrous cycle lysis of the CL is thought to be 
taking place (Stabenfeldt etal, 1981). Neely eta l (1979a) suggested that 
PGF-2a is released from the uterus during luteolysis, leading to raised PGFM con­
centrations in the circulating plasma and lysis of the luteal tissue. This study 
agrees with these findings. PGF-2a production by the endometrial tissue 
increased during the late luteal phase around the expected time of luteolysis and it 
would seem likely that this PGF-2a was involved in lysis of luteal tissue. However 
in this study PGF-2a production from luteal tissue was also demonstrated. By 
comparison of the results of PGF-2a production of the two different tissues (Table 
4:10) it appeared that synthesis and release from the endometrial and luteal tissue 
was almost equivalent at the relevant stages of the oestrous cycle at all incubation 
times. Although there appeared to be a slight increase in endometrial produc­
tion compared to luteal production after 60 minutes incubation at the late 
luteal phase, in the endometrial samples the standard error was greater, suggesting 
that PGF-2a production by the tissue from the different mares was not so consist­
ent as that recorded in the luteal samples.
These results agree with the findings in other domestic species ie the rat 
(Olofssun et al, 1988), pig (Guthrie, Roxroad and Bolt, 1978), cow (Shemesh and 
Hansell, 1975) and rabbit (Daniels et al, 1988) that the CL is capable of synthesis­
ing and releasing PGF-2a at the expected time of luteolysis. Although the timing 
of the exact stage of the oestrous cycle was not accurate in this study, 
progesterone production by the luteal cells and plasma progesterone were still 
high. Therefore PGF-2a production by the luteal cells occurred prior to the
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fall in progesterone concentrations associated with luteolysis. It would seem 
likely that this PGF-2a becomes actively involved in lysis. Workers suggested 
that PGF-2a released by the CL of the other domestic species was involved in 
lysis of luteal tissue and the return to standing oestrus. The pig is of particu­
lar interest as it resembles the mare in that no counter-current exchange 
mechanism exists (Harrison, 1979). To increase the concentration of 
unmetabolised PGF-2a at the CL it was hypothesized that not only PGF-2a 
released from the endometrium but PGF-2a released from the CL was also 
involved in luteolysis in this specis (Patek and Watson, 1976). In marsupials hys­
terectomy has no effect on luteolysis. The interoestrous periods are not disrupted. It 
would appear in these species that intraluteal prostaglandins are the sole source of 
luteolytic prostaglandins (Gemmell, 1984).
Ginther and First (1971) demonstrated that, in the mare, hysterectomy 
leads to prolonged inter-oestrous periods and irregular cycles. However although 
the uterus is vital to the regular cycle of the mare a more complicated interaction of 
events may occur, involving integration of uterine and luteal PGF-2a to ensure 
lysis proceeds to completion. Therefore PGF-2a production by the uterus maybe 
the trigger required to stimulate PGF-2a production from the luteal cells. This 
would solve the apparent anomaly of PGF-2a, a locally acting compound, travell­
ing from the uterus to the ovary, via the systemic circulation, to bring about 
luteolysis. Luteal PGF-2a, released at the site of action, would not be subjected 
to metabolism by the lungs and so a high concentration of unmetabolised 
PGF-2a would be available at the CL to bring about luteolysis and the return to 
standing oestrus.
The histological investigations into the cells of the CL of the mare carried out 
in this study indicate that two distinct cells types may be present at different stages 
of the oestrous cycle.
During the mid luteal phase of the cycle small dark cells were evident 
along the edge and around the periphery of the CL. During the late luteal phase 
the numbers of dark cells present in the CL appeared to increase, although the 
actual percentage increase was not quantified. By relating the histological find­
ings of the two distinct cell types to the PGF-2a production results from the luteal 
tissue at the different stages of the oestrous cycle, tends to suggest that PGF-2a
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production from the luteal cells increased as the numbers of dark cells present 
in the luteal tissue increased.
In the ewe, Silvia et al (1984) reported that the two types of luteal cells were 
physiologically distinct. In the mare it is possible that the two cell types are also 
physiologically distinct and that the large luteal cells are concerned with progester­
one production, while the small dark cells are involved with the synthesis and 
release of PGF-2a. This could explain the relatively low PGF-2a production during 
the early and mid luteal phases when the majority of the luteal cells are the large, 
pale progesterone secretors. As the CL ages and the number of dark cells 
present in the luteal tissue increases so the capacity of the CL for PGF-2a produc­
tion markedly increases. Therefore, around the time of luteolysis, adequate 
numbers of dark cells are present, synthesising high concentrations of PGF-2a. 
However without an accurate method of ageing the luteal tissue and a method for 
identifying the different cell types and their relative percentages, no firm con­
clusions regarding the role of the different luteal cell types in the mare can be drawn 
from the findings in this study.
In an attempt to determine if oxytocin is involved in stimulating PGF-2a 
production from the luteal and endometrial tissues of the mare, exogenous oxy­
tocin was added to the luteal and endometrial tissue incubates in this study. 
Oxytoxin has been reported to play an important role in the control of PGF-2a 
synthesis and release from the endometrium during luteolysis in several of the 
domestic species (Wathes, 1984), including the mare (Tetzke et al, 1987). Tan et 
<3/(1982) also demonstrated that oxytocin exerted a luteolytic effect on the CL of 
the human. King and Evans (1987) demonstrated an increased production of 
PGF-2a from endometrial cells removed from the uteri of mares and cultured in 
vitro, in response to oxytocin added to the incubation medium. These workers con­
cluded that oxytocin played some role in luteolysis in the mare, being involved in 
the stimulation of PGF-2a production from the endometrium. In this study the 
effects of oxytocin on PGF-2a production by the luteal and endometrial tissues 
did not give consistent results (Tables 4:12-15). In the luteal tissue explants an 
inhibitory effect was observed during the early luteal phase, although at 30 min­
utes incubation a massive increase in PGF-2a production by the tissue was 
observed. This was caused by the very high result from one sample and if this 
sample was removed no increase at this stage was observed therefore this effect was
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likely to be an artefact. During the mid luteal phase oxytocin did not have any 
effect on PGF-2a production at all. By the late luteal phase however oxytocin 
appeared to exert an inhibitory effect on PGF-2a production by the luteal and 
endometrial tissues. In the single cell suspension cultures oxytocin exerted no 
effect on PGF-2a production at any incubation time or at any dose rate, in either 
the luteal or endometrial cells.
Due to the contradictory results of the single cell suspensions and the tissue 
explants the results from the explant samples were placed in doubt. The explant 
tissue culture was a cruder method with smaller numbers of samples and only one 
dose rate of oxytocin used, therefore it was assumed that these results were not a 
true reflection of the effect of oxytocin on PGF-2a production by the luteal or 
endometrial tissues. The results from this study therefore suggest that exogenous 
oxytocin added to the tissue incubates does not exert a stimulatory or inhibitory 
effect on PGF-2a synthesis and release by either the luteal or the endometrial 
cells. This would suggest therefore that oxytocin is not involved in the events of 
luteolysis in the mare. These findings agree with those of Neely et al (1979b) 
and Arthur and Allen (1972) who were unable to induce precocious oestrus in 
mares in dioestrus with injections of exogenous oxytocin. In addition Flint and 
Sheldrick (Per Comm) were unable to demonstrate significant concentrations 
of oxytocin in the plasma of several mares throughout the oestrous cycle.
These workers concluded that oxytocin was not involved in luteolysis in the mare.
It is now evident that there are several flaws in the single cell suspension 
method used in this study. The problem of preservation of the tissue has already 
been discussed. The concentration of cells in each aliquot was too low. The concen­
tration should probably have been about 1 x 105cells/ml instead of 1 x 
103cells/ml. This increased concentration may have lead to more consistent 
results and lowered the standard errors. Although the viability of the cells was 
checked by the addition of Trypan blue to a sample of the cells, this percentage 
was not taken into account. It was felt that as all the cells had been treated in the 
same manner and as the percentage was approximately the same in each case 
(about 60% viability. This is low compared to other workers who got > 7 5 %  
viability), a correction for this percentage did not have to be taken into account. 
However it is now considered that a correction for viability should have been
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included as, due to the freezing of the cells, a decreased and variable viability was 
likely to have occurred, as Table 4:16 demonstrates.
However despite these problems, the studies undertaken in this thesis do 
tend to suggest that in the mare the pattern of prostaglandin release from the luteal 
tissue at the different stages of the oestrous cycle mimics the pattern of prostaglan­
din release from the endometrium. Although a comparison of the actual values is 
difficult, considering the nature of the assay and tissue culture method, it does 
seem that the concentrations of PGF-2a released by the CL, compared to those 
released by the uterine endometrium, are equivalent at all incubation times, dur­
ing all the stages of the oestrous cycle. This would suggest that the CL is an 
important source of PGF-2a during luteolysis. PGF-2a released by the uterine 
endometrium must first pass through the lungs, where extensive metabolism is 
thought to take place, before reaching the ovary. PGF-2a released from the CL is 
not subjected to this metabolism and so a high concentration of unmetabolised 
PG F-2aatthe CL would be obtained by the addition of luteal prostaglandin 
to the unmetabolised PGF-2a reaching the ovary from the uterus. This would 
allow lysis of the CL despite extensive prostaglandin metabolism in the lungs. 
The control mechanisms for luteal prostaglandin release are unknown, even in the 
species where luteal prostaglandins are known to be involved. From this study it 
would appear that oxytocin is not involved in stimulating PGF-2a release from the 
endometrium or CL in the mare, as in other species such as the ewe. It was con­
cluded therefore that oxytocin was not involved in the events of luteolysis in 
the mare.
The results from this study therefore suggest that the uterus of the mare is 
not the only source of PGF-2a involved in luteolysis in the mare, but a 
more complicated interaction of events is involved with input from both the ovary 
and the uterus bringing about the ultimate demise of the CL and the return to 
standing oestrus.
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5 CHAPTER FIVE 
GENERAL DISCUSSION
The work presented in this thesis represents the results of an investigation 
into the mechanisms involved in luteolysis in the non-pregnant, cycling mare 
and some of the effects of prolonged dioestrus in the mare.
Ovulation had to be accurately recorded to determine the approximate 
time of luteolysis. Initial investigations therefore involved monitoring four mares 
throughout one oestrous cycle by palpation per rectum to allow assessment of 
the state of the reproductive tract, in particular the ovary and the cervix. A 
suggestion that the cervix may relax during luteolysis was not confirmed by closer 
study, therefore changes in the cervix could not be used as an aid to predicting the 
time of luteolysis. Plasma progesterone estimations were carried out to allow 
correlation of the hormonal changes with changes in the reproductive tract. This 
allowed expertise to be established in the estimation of the time of ovulation. 
Luteolysis was assumed to occur fourteen days after ovulation.
During luteolysis the compound prostaglandin F-2 alpha (PGF-2a) is released 
from the uterus and is thought to bring about lysis of the corpus luteum (CL) and 
the return to standing oestrus (Neely et al, 1979a). To try to determine the patterns of 
PGF-2a release two mares were blood sampled throughout one oestrous cycle, initially 
twice daily, but increasing to four times daily as luteolysis approached. PGF-2a has 
a short half-life (Piper etal, 1970) therefore the metabolite 13,14 dihydro 15 keto 
prostaglandin F-2 alpha (PGFM), which has a longer half-life, can be assayed as a 
relatively accurate marker of PGF-2a release (Kindahl, 1981). As PGFM is a small 
compound, variations in the radio-immunassay results frequently appeared and several 
problems had to be resolved, but eventually a relatively consistent PGFM assay was 
established. However examination of the two mares gave little information 
regarding PGFM patterns in the plasma as the blood sampling had not been earned 
out frequently enough. It was found that 3-6 hourly sampling was not adequate to 
establish an accurate pattern of PGFM release. Hourly blood sampling was therefore 
performed for a 38 hour period at the expected time of luteolysis and pulses of PGFM 
were recorded in the plasma of two mares. However as the full luteolytic period 
was not covered using this method the duration of the blood sampling period
155
was increased to 57 hours. A pattern of PGFM in the plasma did then became appar­
ent from the additional information that was available. A single large pulse of PGFM 
occurring prior to the drop in progesterone, appeared to initiate PGF-2a release at 
around Day 14 post-ovulation. There then followed several smaller pulses of 
increased frequency and a drop in progesterone to baseline. In most of the mares 
examined the largest pulse of PGFM recorded was not observed until progesterone 
concentrations had reached baseline, possibly due to a negative feedback of proges­
terone on prostaglandin release. This pulsatile release of PGF-2a appeared to be 
important to the outcome of luteolysis. Thorbum et al (1973) demonstrated that a 
series of surges of PGF-2a was required to bring about lysis of the CL in the ewe. 
Although the majority of the mares examined demonstrated a drop in progesterone 
concentrations and a return to standing oestrus three of the mares examined did not 
return to standing oestrus. They remained in a state of prolonged dioestrus with 
raised progesterone concentrations, despite two of the mares exhibiting raised PGFM 
levels. However the pulses of PGFM released appeared to be of a reduced magnitude 
compared to the normal cycling mares. Although PGFM is an accurate marker for 
PGF-2a it gives no indication as to the source of the PGF-2a. It was therefore 
considered that there may be a secondary source of PGF-2a other than the uterus. It 
was hypothesized that this secondary source was not stimulated to release PGF-2a in 
mares in prolonged dioestrus and so prostaglandin was unable to reach adequate 
concentrations at the CL during luteolysis, thereby preventing lysis from taking 
place. The ovary was considered the most likely secondary source of PGF-2a.
To determine if a secondary source of PGF-2a was present in the ovary of the 
mare, sections of luteal tissue and endometrial tissue were removed from freshly 
slaughtered mares and frozen in liquid nitrogen. The endometrial tissue was used for 
comparison purposes. The gross anatomy and histology of the ovary and, in particu­
lar the CL, had to be examined to estimate the approximate stage of the oestrous cycle, 
as the reproductive history of the mares was not available. The tissue was then 
grouped into four types:
1) Early luteal phase
2) Mid luteal phase
3) Late luteal phase
4) Follicular phase
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A method was established for in vitro culture of the tissue from the mares and a 
radio-immunassay for PGF-2a estimations in the tissue culture supernatant was 
also set up. The differences in production ofPG F-2aby the various tissues during 
the four stages of the oestrous cycle outlined above were compared. It appeared that 
PGF-2a was released by the luteal cells of the mare at all stages of the oestrous 
cycle, but that this production was markedly increased during the late luteal phase 
of the cycle, around the expected time of luteolysis. This luteal PGF a  production 
compared closely to the PGF-2a production from the endometrial tissues. Aspirin 
added to the culture medium inhibited PGF-2a production indicating that the con­
centrations in the supernatant were due to de novo synthesis. It was hypothesized that 
this release of PGF-2a from the CL must be closely involved in luteolysis, as the tissue 
and plasma progesterone concentrations were increased during this time, suggesting 
that the CL was active and luteolysis was not yet complete. This luteal PGF-2a pro­
duction was thought to raise concentrations of unmetabolised PGF-2a reaching the 
CL from the uterus, bringing^about lysis of luteal tissue and the return to standing 
oestrus. Due to inaccuracies in ageing of the tissue it was not possible to determine 
which of the two sources of PGF-2a was released first. Ginther and First (1971) dem­
onstrated the importance of the uterus in the cyclicity of the mare therefore it is poss­
ible that the uterus is the trigger for luteolysis to begin but the CL is the final 
effector in luteolysis.
To try to determine if oxytocin was involved in the stimulation of PGF-2a 
production from either the CL or the endometrium during luteolysis, exogenous 
oxytocin was added to the tissue culture medium and the effects observed. Oxytocin 
did not appear to lead to an increased PGF-2a production at any stage of the 
oestrous cycle from either the luteal or the endometrial tissue and it was concluded 
that oxytocin was not involved in luteolysis in the mare.
During the histological investigations it appeared that there were two distinct 
luteal cell types, large and small, present in the CL. It was hypothesized that these 
small cells were involved in the synthesis of PGF-2a during luteolysis as their 
numbers appeared to increase with the ageing of the CL, reaching maximum at 
expected time of luteolysis. The large luteal cells are thought to act as progesterone 
producers.
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Investigations from this study revealed that luteolysis in the mare was more 
complicated than first anticipated. It appeared to involve the integration of uterine 
and luteal events leading to the release of adequate concentrations of PGF-2a in a 
crucial pattern of pulses at a crucial stage in the oestrous cycle, in order to bring 
about luteolysis and the return to standing oestrus. Any breakdown in communica­
tion between the two areas may prevent the mare from returning to standing oestrus 
and entering a state of prolonged dioestrus.
During the course of this study several areas were raised that require further 
investigation. To further clarify if the CL is an important source of PGF-2a it 
would be possible to determine if the enzymes for PGF-2a synthesis were present in 
the cells of the CL and if there was any difference between the two luteal cell types in 
this respect. By using monoclonal antibodies the heterogenicity and interdependence 
of the two luteal cells could be determined and the possibility of the small dark cells 
being responsible for PGF-2a production further investigated.
In addition, cannulation of the ovarian artery and vein of the live mare would 
allow assessment of the concentration of unmetabolized PGF-2a entering and leav­
ing the ovary and these results, when compared to the jugular PGFM concentrations, 
may give some indication of the source of unmetabolised prostaglandin reaching the 
CL. One important area not yet investigated in the mare is the percentage of PGF-2a 
metabolised on one passage through the lungs. Davis et al (1980) reported differing 
rates of metabolism in different species. These workers reported a slower rate of 
metabolism in the sow than in the cow or sheep. This is interesting from the fact 
that the sow, like the mare, does not have a counter-current exchange mechanism 
bypassing the systemic circulation. Heep, Fleet and Hamon (1985) reported the 
transfer of PGF-2a from uterus to ovary in the ewe via the lymph channels thus 
bypassing the systemic circulation. Alawachi, Bland and Poyser (1981) reported that 
transfer of PGF-2a could also take place via the oviducal vein, suggesting that the 
counter-current mechanism is not the only pathway of exchange. Therefore the 
importance of these two routes to the transfer of PGF-2a from uterus to ovary in 
the mare must be calculated before the importance of a secondary source of 
PGF-2a can be fully elucidated.
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It would also be interesting to determine the source of PGFM in the plasma of 
mares in prolonged dioestrus, as it may be that PGF-2a is released from the 
endometrium of these mares but not from the CL, causing a decreased concentration 
of unmetabolised PGF-2a at the CL, thus preventing lysis from taking place. To 
determine the source of the PGF-2a released in these mares, samples of endometrial 
and luteal tissue could be removed and cultured in vitro to determine production 
rates from both tissues and to compare to PGF-2a production from endometrial and 
luteal tissue from normal cycling mares. It would also be worthwhile to calculate 
the relative percentages of light and dark cells present in the CL of these mares and 
compare this to the relative percentages in normal cycling mares.
It thus appears that many aspects of luteolysis in the mare remain unclear and 
further intensive study is required to fully elucidate these points. An increased knowl­
edge of the events of luteolysis and why they frequently breakdown in the mare 
would allow more control over the oestrous cycle of the mare thus increasing her 
productivity.
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